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B iological systems are complicated, formed of many interacting parts. Network scienceis well placed to attempt to elucidate these systems, and it is important to further ourunderstanding to look at different biological networks across scales and applications.
For this thesis, we examined two biological systems that can be described with networks: gene
regulatory networks (GRN) and functional brain networks. We developed and analysed a novel
GRN describing pluripotent mouse embryonic stem cells (mESCs) dynamics. Pluripotency is
controlled by a complex GRN; understanding the interplay between the network elements and
factors present in the different media cultures could help define optimal culture protocols. We
expanded an existing GRN describing Nanog (a master regulator of pluripotency) dynamics to
include additional genes and both chemicals present in ground-state pluripotency media, i.e.
2i+LIF. We showed, using stochastic differential equations and bifurcation analysis, that the
experimental dynamics of Nanog result from the combination of feedback loops in the GRN
and transcriptional noise, giving rise to bistability. The functional brain network analysis we
performed was in exploring Multiple Sclerosis (MS), a demyelinating disease of the central
nervous system. This damage does not correlate with impairment, suggesting the brain can
undergo neuroplasticity to compensate. We used functional magnetic resonance imaging (a
technique to indirectly measure activity in the brain) collected in Bristol (CRICBristol) to explore
neuroplasticity. We preprocessed the scans, extracted time series from regions of interest (ROI)
and measured the functional connectivity (FC) between each ROI time series. We abstracted the
brain to a network, where nodes are different regions of the brain and edges represent the FC
between them. We measured different properties of the networks and compared them between
MS and healthy controls (HC). We found no evidence of neuroplasticity between MS and HC,
which could be because the MS cohort brains have already successfully undergone plasticity
to compensate for the damage caused. Future work for the GRN network could be in using it
to understand how chemicals known to interact with its elements could be applied to control
pluripotent behaviour of mESCs. For the functional brain networks, a dynamic causal modelling
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B iological systems are complex, often comprised of many intricate and interacting parts.For example, there are approximately 20,000 genes in the human body [155]. These allinteract with each other as well as molecular pathways to create the body and maintain
the homeostatis of various organs. Another example is in the human brain which contains ap-
proximately 100 billion neurons [63] with many more connections between them, giving rise to
the control centre of the body vital for its survival.
The complexity of these systems can lend naturally to modelling them as networks, where
the nodes and edges can have distinct biological meanings. In biological systems it is important
to consider them as a whole, as well as account for temporal dynamics of the variables of interest.
With this understanding, new treatments for diseases, or protocols for in-vitro research, might be
better informed. Mathematical modelling is a useful tool, which can be used to represent biologi-
cal networks, complementing physical experiments and allowing a quantitative understanding
of the system dynamics. We studied two different biological networks. The first was a network
describing interacting genes in stem cells; we explored models of different in-vitro growing
conditions and analysed how this could change the expression of the genes being modelled and,
ultimately, stem cell phenotype. The second network involved the communications within the
brain; we investigated how network properties of these functional networks might differ between
different populations of interest.
In Chapter 2 we looked at how interactions among proteins, forming Gene Regulatory Net-
works (GRNs), can determine the fate of mouse embryonic stem cells (mESC) and their propensity
to differentiate into specialized cell types. mESCs have a property called pluripotency, meaning
1
CHAPTER 1. INTRODUCTION
they can divide and give rise to other cells still able to differentiate into any cell type. These cells,
isolated from mice, can be indefinitely cultured in the lab to study development in-vitro, where
significant research effort has been put into defining optimal culture conditions for pluripotency
maintenance. The most notable pluripotency gene is Nanog [20], regarded as a master regulator of
pluripotency. Nevertheless, mESCs can respond differently to culture media and express different
concentrations of genes important for pluripotency. Cells expressing high concentrations of Nanog,
Nanog high (NH), posses greater pluripotency and therefore less propensity to differentiate. The
opposite is true for Nanog low (NL) cells. Additionally, mESCs are capable of switching between
NH and NL states due to temporal fluctuations of Nanog [4], with similar behaviour observed in
other pluripotency factors. These cells can be cultured in media [145]: Serum+LIF and 2i+LIF,
where Serum+LIF containins serum factors and leukaemia inhibitory factor (LIF) and 2i+LIF is
more recently established, replacing serum factor with two inhibitors called PD and Chiron. In
these media, mESCs of a previously proposed cell line type termed TNGA display heterogeneous
levels of Nanog in Serum+LIF, which when cultured in 2i+LIF is lost [159], replaced by an
observed pure NH distribution. This ‘ground-state’ of pluripotency has recently been challenged,
with a newer cell line type, termed ND [3], not displaying an elimination of the NL phenotype in
2i+LIF.
We focussed on the temporal dynamics of Nanog, combining modelling and experiments to un-
derstand how its heterogeneous expression and temporal dynamics depend on the culture media
and regulate both cell pluripotency and cell division. Many modelling types and mechanisms have
been put forward to explain heterogeneity of pluripotent genes. We extended an existing GRN
for pluripotency, and used stochastic differential equations (SDEs) to describe interactions of
core pluripotency genes and their dynamics. The mathematical model successfully recapitulated
the heterogeneous levels of Nanog observed experimentally, and explained them through the
combination of feedbacks in the GRN, transcriptional noise and the chemicals present in the
culture media. The work in this chapter has been published in Nature Partner Journals Systems
Biology and Applications [55].
Another biological system we looked at was based on functional brain networks in Mul-
tiple Sclerosis (MS), a demyelinating disease of the central nervous system. MS is a leading
cause of disability in young adults and a major health burden [17, 80]. We were interested in
what compensatory mechanisms the MS participants brains may undergo to limit the effects
of the demyelination, which could inform on disease progression or the effectiveness of treatments.
Chapter 3 is a systematic review, a type of literature review used in clinical settings. The re-
view focused on functional magnetic resonance imaging (fMRI) which measures oxygenated blood
flow around the brain, called the blood oxygen level dependent (BOLD) signal. This signal can be
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used as a proxy for brain activity, as more active regions of the brain require more oxygenated
blood. In particular, the review looked at studies analysing MS with resting-state fMRI, a type of
fMRI paradigm that measures basal connectivity and has the advantage of requiring no task or
paradigm that could be arbitrary or subject to bias. The review looked at what evidence in the
literature shows neuroplasticity in the brains of MS to compensate for their damage.
For Chapter 4 we carried out a study of data obtained from MS participants and healthy
controls (HC). We performed resting-state fMRI scans on all the participants, and applied network
analysis techniques to their BOLD time series. The aim was to determine if there were any differ-
ences between MS and HC which could be evidence of neuroplasticity, i.e. the brain forming new
connections to compensate for the damage. Specifically we were looking for evidence which could
explain the increased fatigue experienced by the MS cohort. This chapter outlines the process of
preprocessing applied to the fMRI data, and the measure of functional connectivity (FC) between
distinct predefined regions of the brain. FC is a statistical measure of correlation between the
BOLD signal of two regions, with higher FC inferring greater communication between them. The
brain can then be abstracted to a network, with regions of the brain being the nodes and the
edges between them being the respective FC. We make standard network measurements of these
functional brain networks like clustering coefficient, small world propensity and modularity. We
then compared the measurements between the two populations to see if any differences occurred,
signifying possible compensatory neuroplasticity.
Chapter 5 is a preliminary investigation of a tool to analyse dynamic FC in fMRI. In this
analysis we developed the application of a Kalman filter to dynamic FC in an attempt to track
and characterize the broad changes to FC over time. The filter behaved like a smoother, broadly











PLURIPOTENCY GENE REGULATORY NETWORKS IN MOUSE
EMBRYONIC STEM CELLS
S tem cells are a special type of cell which have the ability to turn into other types of cell,after which they may perform specialized functions needed for an organism to survive. Amouse embryonic stem cell (mESC) is a type of stem cell found in the developing embryos
of mice which can differentiate into all the cells needed for the embryo to develop into a body.
Significant research has been performed on mESCs to define optimal ways in which they can be
maintained in-vitro into the pluripotent state, and to identify protocols in which their differentia-
tion can be controlled. This could pave the way for future research which could use these cells for
regenerative medicines, replacing lost or damaged cells the body cannot repair by itself.
The work in this chapter was published in Nature Partner Journals Systems Biology and
Applications [55], where the results of the work I performed are in Sections 2.4.1, 2.4.2, 2.4.3,
2.4.4 and 2.4.5. The work behind the results of Section 2.4.6 were performed by collaborators.
2.1 Biology background
When a mouse egg cell is fertilized a single cell Zygote is formed. This cell continuously divides
forming a mass collection of cells after 3-5 days called a blastocyst. Figure 2.1 shows an illustration
of a single fertilized egg cell forming into a blastocyst. The blastocyst is broadly formed of two
cell types; those which form its outer wall structure, and a group of cells inside called the inner
cell mass. The inner cell mass is where mESCs are taken from.
mESCs can differentiate into almost any type of cell in the body. However once a mESC
has turned into, for example, a skin cell, it remains this new cell type. A mouse embryo needs
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Blastocyst: 
3-5 days after fertilization
Single cell Zygote
Inner Cell Mass
Figure 2.1: Illustration showing the formation of a blastocyst where mESCs
are taken from the Inner Cell Mass.
a plentiful supply of mESCs, and the ability to create more of them in order to form all the
necessary components of its body. To achieve this mESCs have a property called pluripotency; this
is where mESCs have the ability to turn into most other cell types. Additionally with self-renewal,
mESCs can split, not into new cell types but more mESCs, and all the mESCs under the right
conditions still retain the ability to differentiate.
In-vivo, mESCs in an embryo are pluripotent as the organism has evolved to be able retain
the right mESC behaviour and switch it on and off when necessary. Studying mESCs in-vitro
requires the correct conditions for successful growing and studying of these cell populations.
2.1.1 Culture conditions
In-vitro, mESCs are grown in culture media; culture conditions can confer different character-
istics to cell populations. Two media of interest are Serum+LIF and 2i+LIF. Serum+LIF is the
more established culture containing serum factors and the cytokine leukaemia inhibitory factor
(LIF). The more recently developed medium 2i+LIF [83] also contains LIF but with two chemical
inhibitors (2i stands for 2 inhibitor) instead of serum factors. The inhibitors are MEK inhibitor
PD0325901, hereafter named PD, and glycogen synthase kinase-3 (Gsk3) inhibitor CHIR99021,
hereafter named Chiron (also sometimes referred to as CH).
Cells grown in Serum+LIF have a flat morphology whereas in 2i+LIF the colonies grow in
more spherical, contained structures [145]. As well as the morphology of the colonies, mESCs
have a number of different characteristics between the two media. These include the differential
expression of genes involved in pluripotency, cell-cycle and cell death.
2.1.2 Pluripotency genes in different culture conditions
Genes are units of inheritance, passed down through the generations. They code for proteins
which then can perform molecular tasks within cells. When mESCs are cultured in Serum+LIF
6
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the population has a heterogeneous expression of genes which govern pluripotency. The most
notable of which is Nanog, a master regulator of pluripotency and development [20]. Cells ex-
pressing high concentration levels of Nanog, the Nanog high (NH) phenotype, display greater
pluripotency and less propensity to differentiate [138]. Nanog low (NL) mESCs have reduced
pluripotency, and therefore a greater propensity to differentiate [138]. Nanog and other pluripo-
tency factors display temporal fluctuations, with single cells switching in time between high
and low states. These factors are also heterogeneous, with many of them, directly or indirectly,
regulated by Nanog, including Rex1, Stella, Essrb and β-catenin [147].
mESCs need to be pluripotent when cultured in pluripotency conditions, while keeping the
ability to differentiate when differentiation stimuli are provided. For this aim, a more uniform
population would have all mESCs expressing the NH phenotype. The newer culture media,
2i+LIF, was developed with the aim of eliminating the heterogeneity observed in Serum+LIF.
An easy way to indirectly measure gene expression is by means of fluorescent proteins, tagging
the gene of interest. More specifically a green fluorescent protein (GFP) can be added to tag
Nanog, where the fluorescence is what is then measured by a special type of microscope which
images florescence. The cell line commonly used to measure Nanog expression is known as TNGA,
which was created by inserting a GFP cassette at the start codon (codons are groupings of three
nucleotides which code for an amino acid) on one Nanog allele (an allele is a variant of a gene).
TNGA mESCs show an almost complete elimination of the NL phenotype in 2i+LIF, suggesting
that 2i+LIF enables complete, or ‘ground-state’, pluripotency in-vitro [159].
Recently, other cell lines have been developed, as it has been noticed that the degradation
rates of Nanog and the GFP tagging Nanog in TNGA cells are different [39]. Due to the discrep-
ancy, this fluorescent reporter is not a good proxy for observing Nanog dynamics. Therefore a
newly developed cell line was created which uses a different fluorescent protein with comparable
degradation rate to Nanog. The new cell line is known as ND [3, 4]. ND mESCs are still heteroge-
neous in Serum+LIF, although the difference between NH and NL is smaller. However, in 2i+LIF
ND mESCs no longer show a complete elimination of the NL phenotype, with a small population
of NL cells still present. This could be considered undesirable if the aim is to keep a population of
pluripotent cells indefinitely.
Figure 2.2 shows concentrations of Nanog, measured by the fluorescent reporters, for the two
cell line types in the different media. Figure 2.2a is for TNGA cells and shows the heterogeneity
of Nanog in Serum+LIF (left panels of Figure 2.2a), which is lost in 2i+LIF (right panels of Figure
2.2a). Figure 2.2a also shows the same behaviour for Rex1, which is considered a direct target of
Nanog, and measured as a proxy for it (see model in Section 2.2.3). Figure 2.2b is for the ND cell
line which in Serum+LIF has a greater proportion of cells in a NL state than TNGA cells (Nd,
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serum/LIF in Figure 2.2b). When the ND cells are grown in 2i+LIF the heterogeneity is reduced
but still present, as shown by the small peak (Nd, 2i in Figure 2.2b, highlighted by *).
a TNGA b ND
Figure 2.2: Concentrations of Nanog and its target Rex1 in different mESC
line types. a TNGA cells, image adapted from [159]. b ND cells (VNP is venus
nanog protein), image adapted from [3]. ND cells labeled Nd, with *
highlighting persistence of NL population.
2.2 Modelling
2.2.1 Gene regulatory network (GRN) model
The central dogma of biology describes the process by which the information of a gene stored
in DNA is transformed into a physical protein able to perform specific tasks. The process is
DNA→mRNA→protein. The step from DNA to mRNA is called transcription and from mRNA to
protein is called translation. Transcription is regulated by proteins called transcription factors
(TF) which bind to certain regions of DNA, increasing or decreasing transcription. Proteins
are the final output of (protein-encoding) genes, and can act as TFs which results in genes
regulating other genes and even themselves. This forms a network of interacting genes, termed
gene regulatory network (GRN) of genes activating and inhibiting other genes. Differential
equations can be used to describe the changing protein levels, incorporating Hill equations to
describe the interaction of a gene activating or inhibiting another gene. See Section 2.2.4 for more
details on Hill equations and modelling GRNs.
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2.2.2 Other mechanisms to model Nanog dynamics
Other modelling types have been put forward to explain the dynamic differences of pluripotent
genes between the two media. A published review [86] outlined different ways of modelling Nanog
dynamics, broadly characterized into four different modelling types: GRN (as above), probabilistic,
allelic switching and protein-protein interaction networks.
GRNs describe transcriptional dynamics of interacting elements, which can involve positive
and negative feedbacks and can also include stochastic elements. These models produce good
agreement with experimental steady-state distributions and single cell dynamics.
Probabilistic models make no assumptions about underlying GRNs, thus they avoid over
fitting of parameters and do not need to introduce assumptions. They are based on probability
distribution functions and Gaussian noise. The example described in the review [78] had just one
variable, that of Nanog.
An allelic switching model abstracted mESCs into four groups, each with a different state
corresponding to altered Nanog behaviour [94]. Each group has a percentage of occupancy and
there are transitional probabilities between the states described by a Markov chain. This model
correctly recapitulated bistability in Serum+LIF, though was not used to model 2i+LIF.
A protein interaction network only considered protein-protein interactions, modelling tran-
scription by a stochastic bursting mechanism [99]. One of their models correctly matched correla-
tions between the genes Oct4 and Nanog (two of the genes considered part of the core pluripotency
network, see Section 2.2.5), and matched their mRNA distributions. However it did make some
incorrect predictions. This model was later improved by adding extra interactions making more
predictions in line with experimental results.
All these different models correctly match distributions of Nanog. However, none took into
account the newer ND mESCs with their persistent NL cells. We therefore wanted to develop a
model able to describe the persistence of NL cells in 2i+LIF, while accounting for factors present
in different culture media.
2.2.3 Reference model
We looked at a previous model of a GRN [62] describing how the concentrations of Nanog and Rex1
differ between Serum+LIF and 2i+LIF. This model was fitted to experimental data generated
using TNGA cells. Their GRN is shown in Figure 2.3a and was described mathematically by
the stochastic differential equations (SDEs) in Figure 2.3b. This network is comprised of the
genes Nanog, heterodimer Oct4-Sox2 and Rex1. Of note, Rex1 is only regulated by other factors,
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and is therefore considered as an output to the model. Included into the model were signalling
pathways of FGF4/Erk and Y/Yin (a differentiation signal we ignored as we were not interested
in differentiation dynamics). Different media conditions were simulated via the value p, set at
15 for Serum+LIF and inhibited to 0 for 2i+LIF. Interactions between network elements were
described mathematically with Hill equations, and noise added as a zero-mean Gaussian pro-
cess. For more details about modelling GRNs, Hill equations and noise see Sections 2.2.4 and 2.2.7.
a b
Figure 2.3: Reference GRN model of [62]. a Diagram of Network interactions.
Core network is within the inner grey box, composing Nanog, heterodimer
Oct4-Sox and Rex1. Respective transcription rates are denoted by Si.
Additional signalling is included; FGF4/Erk inhibiting Nanog with rate p and
a differentiation signal Y (which we ignore in this thesis). b Equations
describing the rates of genes involved in the network using Hill terms,
resulting from the GRN interactions. Si are maximum transcription rates, di
are degredation rates, 1/k is the Michaelis–Menten constant and σi are noise
amplitudes added to each network factor.
The developers of the reference GRN model simulated it 10,000 times, and recorded the
concentration of Rex1 at the end of each run. The resulting distribution of Rex1 values are shown
in Figure 2.4a and 2.4b for Serum+LIF and 2i+LIF respectively, on top of measured Rex1 data.
Their model correctly matched TNGA Rex1 tagged data, with a complete elimination of NL cells




Figure 2.4: Simulation results of Rex1 distributions in reference model
compared to Rex1 data. Images adapted from [62]. a Serum+LIF results. b
2i+LIF results.
2.2.4 How to model a GRN
The reference model used a GRN to describe the changing behaviour of Nanog between the two
media. Below we derive Hill equations showing how they model transcription saturations, and
we demonstrate how to incorporate them into the mathematical framework of a GRN.
Hill equation derivation
The derivation described here is based on the work in [6]. Transcription is the process by which
mRNA is produced in a cell requiring a special protein called a transcription factor (TF) to bind
to a certain region of the DNA. TFs either activate the transcription process or they inhibit it,
and as the concentration of TF increases the rate at which transcription happens saturates. Hill
equations are commonly used to describe transcription rate saturation in GRNs. A Hill term for
activation is
S · [A]n
Kn + [A]n ,(2.1)
and for inhibition is
S ·Kn
Kn + [A]n .(2.2)
Concentrations are denoted in square brackets ([ ]). S is the maximum rate, [A] is the concen-
tration of substrate of interest, n is the Hill coefficient describing cooperativity and K is the
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Michaelis–Menten constant which is also the concentration of substrate ([A]) required for the
Hill term to be half of its maximum value.
Deriving the Hill equation starts by considering the process of TF binding. Figure 2.5 shows
an illustration of a TF (A in diagram) and a binding site on the DNA (B in diagram) to which the
TF can attach. When the TF is attached to the binding site it forms a complex (C in diagram) and







Figure 2.5: Illustration of a transcription factor (A) attaching to a binding site
(B), forming a binding site complex (C), allowing transcription (indicated by
bent arrow) to occur.




where A is the transcription factor, B is the binding site, C is the factor-complex formed, k1 is
the rate at which the complex is formed and k2 is the rate at which the complex is broken back
into the TF and free binding site.
The law of mass action states that the rate of a reaction is linearly proportional to the
concentration of its reactants, and can be used to define differential equations describing how
the concentrations of the three reactants (TF, binding site and complex) change over time. The













for TF, binding site and complex, respectively.
These differential equations can be simplified by assuming that all the reactants are in a
‘quasi steady-state’. This assumes that the process by which the TF binds and unbinds happens








= 0 =⇒ [C]= k1
k2
[A][B].(2.7)
The rate of mRNA production is proportional to the portion of binding sites that are bound by




= S · [C]
[B]+ [C] −dm · [m],(2.8)
where m is mRNA concentration, S is a proportionality constant equivalent to the maximum
transcription rate and dm is the degradation rate. Substituting in the terms found from quasi















The final Hill equation describing how the rate of mRNA production is affected by a TF, for
the case when the TF acts as an activator is shown, with added degradation by
d[m]
dt
= S · [A]




The case when the TF acts as an inhibitor is represented in Figure 2.6. This assumes that the
gene is already in the process of transcribing before the TF binds. After binding, transcription is
stopped.
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Figure 2.6: Illustration of a transcription factor (A) attaching to a binding site
(B), forming a binding site complex (C), stopping transcription (red cross).
The case for inhibition is the same as for activation as in equations (2.3) to (2.7), except the
rate of mRNA production is now proportional to the portion of binding sites not bound by a TF
minus some degradation, as shown by
d[m]
dt
= S · [B]
[B]+ [C] −dm · [m].(2.11)
Substituting in the terms found from quasi steady-state (equation (2.7)) and taking out
common factors leads to
d[m]
dt
= S · [B]
[B]+ k1k2 [A][B]










The final Hill equation describing how the rate of mRNA production is affected by a TF, for








We examine one more scenario, where two TFs form a homodimer and activate transcription









Figure 2.7: Illustration of two transcription factors (A) formed as a
homodimer, attaching to a binding site (B), forming a binding site complex (C),
allowing transcription (indicated by bent arrow) to occur.




Here the reaction requires two TFs, where A is a transcription factor, B is the binding site, C
is the factor-complex formed, k1 is the rate at which the complex is formed and k2 is the rate at
which the complex is broken back into TFs and free binding site. The law of mass action is again
used to describe the rate of change of concentrations of the three reactants (TF, binding site and











for TF, binding site and complex, respectively.
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The rate of mRNA production is again proportional to the portion of binding sites bound by
TFs, with added degradation. The differential equation describing the production of mRNA for
the TF homodimer activating transcription is given by
d[m]
dt
= S · [C]
[B]+ [C] −dm · [m],(2.19)
where m is mRNA concentration, S is the proportionality constant and dm is the degradation

















The final Hill equation describing how the rate of mRNA production is affected by two TFs,
for the case when they act cooperatively as activators and with added degradation, is given by
d[m]
dt
= S · [A]
2





For two TFs cooperatively inhibiting transcription, mRNA rate is proportional to portion of










Extending this to even more TFs acting cooperatively is simply a case of increasing the
exponents of A and K . This exponent is known as the Hill coefficient. The rate of mRNA
production for a general number of TFs, n, cooperatively activating is given by
d[m]
dt
= S · [A]
n

















This only describes how the concentration of mRNA is affected by a TF. Describing how
the end protein concentration is affected requires one more step. Transcription dynamics can
be assumed to occur on a much faster time scale than translation, and the quasi steady-state





= S · [A]
n




· S · [A]
n
Kn + [A]n .(2.26)
The rate of change of protein is assumed to be proportional to the concentration of mRNA,




where α is a proportionality constant and dp is the degradation rate of the protein. This form
ignores basal/background transcription that can occur due to random movements of the DNA
strands and other unexplained molecular mechanisms.
The final equation describing how the concentration of a gene’s protein (p) is regulated by a
TF (A) is found by substituting equation (2.26) into (2.27) and is given by
d[p]
dt
= Sp · [A]
n













for activation and inhibition, respectively. Sp is the maximum protein production rate and K is
the Michaelis–Menten constant.
Describing a GRN with Hill equations
Hill equations can be used to describe the interactions of a GRN under a few assumptions. The
process of transcription in an individual cell is binary, it is either happening or it is not. The Hill
equation is a smooth function ranging between transcription and no transcription. Therefore
it can only be applied when considering a large of number of cells, modelling a distribution of
transcription in a population.
How to apply Hill equations to describe a GRN is described here by an example. Figure 2.8
shows two simple made up gene networks, with Figure 2.8a being a single gene, B, activated
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Figure 2.8: Two simple GRNs to demonstrate application of Hill equations to
describe gene interactions. a Simple gene network with single activation (A
activating B indicated by arrow). b Simple gene network with single activation
and single inhibition (A activating C indicated by arrow, and B inhibiting C
indicated by flat-headed arrow).
by another, A. Figure 2.8b shows a single gene, C, being regulated by two other genes; A which
activates it, and B which inhibits it. This example is to demonstrate how to describe a gene’s
affect on another gene, therefore only Gene B in Figure 2.8a and C in Figure 2.8b are considered.
The activation of A on B in Figure 2.8a can be described with a Hill equation as given by
d[B]
dt
= SA · [A]
n
Kn + [A]n −dB[B].(2.30)
The regulation of A and B on C, as in Figure 2.8b, can be described as given by
d[C]
dt
= SA · [A]
n
Kn + [A]n +
SB ·Kn
Kn + [B]n −dC[C],(2.31)
where two Hill terms (one for activation, one for inhibition) are added together. This assumes the
regulation from TFs act as an OR gate. The Hill coefficient n, as well as the other parameters (K ,
the Michaelis–Menten parameter; di and Si, the degradation rate and maximum transcription
rate respectively of substrate i) can be chosen based on experimental data or desired system
behaviour. This method can then be extended to a larger GRN, forming differential equations for
each element of the network by summing Hill terms associated to every element which acts on it.
2.2.5 Bistability in an idealised ‘core’ GRN
Nanog, Oct4 and Sox2 are considered the core genes involved in pluripotency and cell fate in
mESCs. The behaviour of Nanog has been shown to be bistable in mESCs in Serum+LIF and
2i+LIF (bistable in 2i+LIF for ND cells not TNGA) [3, 4, 159], displaying two different stable
18
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levels of the gene, termed Nanog high (NH) and Nanog low (NL). The genes Oct4 and Sox2 act
together as a heterodimer [23] and its concentration levels have been shown to be stable at a
single concentration level, with little fluctuation [19, 138]. We recapitulate how the bistability of
Nanog can be derived from a simple ODE in this section, starting from the reference GRN and
simplifying it.
Figure 2.9 shows two different GRN interactions of the core genes, suggested in [23] for
Figure 2.9a and [62] for Figure 2.9b (we removed Rex1 as it is not considered a part of the core
network). Oct4-Sox2 is a heterodimer, whose process of formation and disintegration is shown
in the GRN of Figure 2.9a. Figure 2.9b simplifies the Oct4-Sox2 heterodimer interaction to a
simple auto-activation. The network in Figure 2.9b also removed the activation of Oct4 and
Sox2 by Nanog as in Figure 2.9a to simplify the network. They were not needed to explain the
main bistable behaviour of Nanog and add extra complexity and parameters to fit. We took the
simplified core network of Figure 2.9b and simplified it further to demonstrate how the bistability








Figure 2.9: Two different GRN schematics of the core genes involved in
pluripotency in mESCs. Solid lines are transcriptional interactions, dashed are
non-transcriptional. a Core pluripotency network as described by [23]. This
shows interactions between the genes Oct4, Sox2, their heterodimer Oct4-Sox2
and Nanog.b Simplified network as in [62] showing only interaction between
the Nanog and the heterodimer Oct4-Sox2. Activation of Oct4 and Sox2 by
Nanog removed as these interactions were not necessary to describe Nanog
dynamic.
The final simplification we made was assuming that the activation of Oct4-Sox2 on Nanog is
weak in comparison to Nanog’s activation of itself. As the distributions of Oct4-Sox2 concentra-
tions are also monostable, Oct4-Sox2 activation on Nanog can be assumed to be constant. This
simplifies the underlying equations of the system to a single ODE which can be easily analysed,
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K2 + [N]2 −dN · [N],(2.32)
where SOS is a small constant representing the weak activation of Nanog by Oct4-Sox2.
This focuses the analysis on the key changing gene Nanog only. Nanog has been shown to
form homodimers [98, 153], motivating a choice of Hill coefficient of 2 for this basic system. We
analysed this system graphically by splitting the RHS into two parts, f (N) and g(N), given by
d[N]
dt
= f (N)− g(N).(2.33)
The two parts f (N) and g(N) are defined as
 f (N)= SOS +
SN ·[N]2
K2+[N]2
g(N)= dN · [N]
(2.34)
where f (N) is the positive contributions to the rate of change and g(N) the negative parts.




Substituting equation (2.35) into (2.33) steady-state points are found by the simple equality
given by
f (N)= g(N).(2.36)
We find steady-state points by drawing f (N) and g(N) and seeing where the curves intersect.
Figure 2.10 shows a plot of the two functions and their three intersections, or steady-states. It
should be noted that these are not nullclines, they are graphical representations of the functions
f (N) and g(N) as stated in equation (2.34). The final consideration in this system is the stability
of the steady-states. This is done by referring back to equation (2.33), where the rate of change
is positive for f (N) > g(N) and negative for g(N) > f (N). The lower part of Figure 2.10 shows
the 1-dimensional space of the concentration [N]. Arrows indicate the direction of changing
concentration, when f (N)> g(N) the rate of change of concentration is positive and so points to
the right. When g(N)> f (N) it is to the left. Steady-states where the arrows point into them are




























Graphical representation of steady-states for the differential equation: d[N]dt = f (N)− g(N) where
f (N) is a Hill equation and g(N) is linear degradation, see equation (2.34). Intersections of the
two curves are where the rate of change of the system is zero. Stability of these states are
determined by looking at the system flow directions either side of them. Stable steady-states are
indicated with and unstable steady-states with .
of the steady-states are stable and the middle one is unstable.
This GRN therefore exhibits bistable behaviour for Nanog, under certain parameter condi-
tions; one NL and one NH stable steady-state separated by an unstable steady-state between
them. The bistability is due to the non linear positive feedback loop on Nanog, and Nanog’s
degradation.
2.2.6 Parameter effects on bistability in the idealised ‘core’ GRN
There are four parameters in this system; SN , SOS, K and dN . The values of these parameters
change the stability behaviour of the core GRN. How these parameters affect the system can be
explored graphically. The degradation rate is kept constant throughout the following exploration,
as seen by the linear diagonal line in all the Figures. Maximum transcription rate is indicated by
a horizontal dashed black line on all the Figures. These demonstrations are qualitative and so no
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specific values are given.
The system stability when changing parameter SOS can be seen in Figure 2.11. Here the
value is increasing from left to right which effectively transposes the Hill function higher. As the
value increases the lower two intersections of the curve come closer together (Figure 2.11a) and
eventually the curves pull apart at a Saddle-node bifurcation (Figure 2.11b), leaving only a single




























Figure 2.11: Graphs demonstrating change in bistability as SOS value
increases a to c. Black dots represent stable steady-states, black-outlined
white dots represent unstable states and half-filled dots represent
Saddle-node bifurcations.
The system stability when changing parameter SN can be seen in Figure 2.12. Here the value
is increasing from left to right, effectively increasing the maximum gene production rate. As
the value increases the non linearity of the Hill term bends it away from the degradation curve
(Figure 2.12a), eventually bending away enough to form a Saddle-node bifurcation (Figure 2.12b)
and then bending fully away leaving only a single high stable steady-state (Figure 2.12c).
The system stability when changing parameter K can be seen in Figure 2.13. Here the value
is decreasing from left to right, increasing the systems sensitivity to increasing TF concentrations.
As the value decreases the Hill term curves more away from the degradation curve (Figure 2.13a),
eventually forming a Saddle-node bifurcation (Figure 2.13b) and then leaving only a single high
stable steady-state (Figure 2.13c). Note the maximum rate (dashed black line) remains constant
throughout changing K .
Another parameter to consider is the Hill coefficient which has previously been set to 2 for































Figure 2.12: Graphs demonstrating change in bistability as SN value
increases a to c. Black dots represent stable steady-states, black-outlined





























Figure 2.13: Graphs demonstrating change in bistability as the
Michaelis–Menten paramater K decreases a to c. Black dots represent
stable steady-states, black-outlined white dots represent unstable states and
half-filled dots represent Saddle-node bifurcations.





Figure 2.14 shows the system as the Hill coefficient is increased, Figure 2.14a to Figure 2.14c.
This coefficient is the main source of non linearity in the system, which displays more non linear
behaviour as the value is increased.
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Figure 2.14: Graphs demonstrating change of system graphs as Hill
coefficient, n, is increased a to c. Black dots represent stable steady-states
and black-outlined white dots represent unstable states.
The previous principles can be used to alter the stability of the deterministic system to a
desired level. For example if the wanted behaviour is for the steady-states to be brought closer




























Figure 2.15: Graphs demonstrating change in bistability as Sn and k values
simultaneously decrease a to c. Black dots represent stable steady-states
and black-outlined white dots represent unstable states.
2.2.7 Stochasticity to encompass complex molecular processes
The system shown so far is deterministic, and any simulation of a cell encompassing that GRN
will always display the same concentration of Nanog, either the NH or the NL steady-state
with no intermediate values. Real mESCs display a continuous distribution of concentration
values due to the fact that they have many more genes, with very complicated regulations and
molecular processes. With current knowledge and technologies, modelling the exact regulations
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of the huge number of processes in a cell is impossible. Therefore noise is added to the system
to approximate it. This changes the ODE from Section 2.2.5 (equation (2.32)) into a stochastic





K2 + [N]2 −dN · [N]+ζ(0,σN ) · [N].(2.38)
The noise is applied as a random variable ζ drawn from a normal distribution with mean 0
and standard deviation σN , multiplied by the concentration of the gene, i.e. [N], and added to
the RHS as in [62]. Simulating a large number of cells produces a distribution of concentration
values for Nanog. The two main ways of adding noise are multiplicative, as described here, and
additive where the noise term is added without multiplying by the gene’s concentration. We chose
to follow the multiplicative approach as in the reference model, due to it better describing the
greater variability in NH as compared to NL; i.e. NH cells are noisier than NL and additive noise
would not capture this behaviour.
2.2.8 Interplay between noise strength ‘σN ’ and maximum transcription rate
of Nanog ‘SN ’
The GRN of the reference model in Section 2.2.3 demonstrates how, in their GRN, simultaneously
changing the maximum transcription rate of Nanog, S4 equivalent to SN in equation (2.38), and
the noise strength can affect the proportion of cells in NH and NL. Increasing Nanog’s auto-
regulatory rate decreases the proportion of NL cells, whilst increasing Nanog’s transcriptional
noise increases the proportion of NL cells.
Figure 2.16: Diagram showing how the proportion of NL (and inversely NH)
cells is altered when changing transcriptional noise and Nanog’s
auto-regulatory rate, adapted from [62].
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We assume this behaviour qualitatively holds for any GRN of Nanog involving positive
feedback and multiplicative noise.
2.3 Extending the reference model
The model we developed starts with the reference model of Section 2.2.3, adding more genes
and molecular interactions to better explain the dynamics underlying pluripotency in mESCs.
The reference model only included one of the two inhibitors present in 2i+LIF, PD. Therefore we
wanted the new network to describe Chiron as well. We additionally wanted the new network to
incorporate genes related to cell-cycle and pluripotency as these have been shown to be affected
in the two media. Additionally the reference model was fitted to TNGA cell data, therefore the
new model was fitted to measured ND cell distributions. The work flow to add these extra genes
and interactions is summarized in Figure 2.17; below we explain the types of experiment used,
how additional genes and their interactions were inserted, and how the inputs present in the
different culture media were accounted for.
Differential 
expression 
CH vs. XAV 
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Figure 2.17: Schematic of the process for identifying transcriptional
interactions not present in reference model. Set ‘1’ is the output from gene
ontology analysis, and set ‘2’ is the output from the CODEX analysis. Numbers
next to each item indicate the number of genes in the respective step.
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2.3.1 Types of experimental data used
We used a number of data sources to expand the GRN, each one containing results from perform-
ing different types of experiment. Three different experiment types were used by the sources;
Rna-seq, ChiP-seq and microarray. Descriptions of these different experiments are in Table 2.1.




Rna-seq Transcribed mRNA from cells are extracted and fragmented. Each
fragment is reverse transcribed into corresponding fragments of
nucleotides called complementary DNA (cDNA). The fragments
of cDNA are then sequenced and aligned to a reference genome
sequence to reconstruct which genome regions were transcribed.
Counting the number of fragments for a specific part of the genome
gives an expression level for that part.
Chip-Seq Chromatin immunoprecipitation sequencing. Protein of interest
is crosslinked (chemically bounded) to DNA of cells in-vivo with
formaldehyde, and the DNA of the cell is then isolated. DNA is
then broken into segments of around 500 base pairs using sonica-
tion. Anti-body specific to the protein of interest is added to isolate
fragments of DNA bounded by the protein, and to reverse the cross
linking, leaving only fragments of DNA previously bound by the pro-
tein. The DNA is copied using polymerase chain reaction resulting
in a sample of DNA bound by the protein. The samples are then
sequenced and mapped to the genome it came from to identify where
the protein bound. This method can only reveal whether a TF has
bound to the regulatory region of a gene, i.e. it cannot say whether
the TF activates or inhibits the transcription.
Microarray A series of microscopic pits, where each pit contains specially engi-
neered strands of DNA. Each pit produces a different target gene,
which in turn produces a fluorescent protein. A TF is added to
each pit and the change in fluorescence measured, with increasing
fluorescence corresponding to the TF increasing the target gene’s
expression and vice versa for a decrease.
Table 2.1: Table showing different types of experiments used to expand the
reference GRN.
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2.3.2 Additional genes
We re-analysed a published data set of genes differentially expressed between the two media [83],
genes expressed higher in Serum+LIF vs 2i+LIF and vice versa. This data set used Rna-seq to
compare expression levels of genes between the two media.
We performed Gene Ontology (GO) analysis using the platform DAVID [64], an online tool
for GO classification. GO is the labelling of genes by their associated biological process (BP).
For each BP, DAVID looks at the number of genes in an input list that are associated with that
BP. It also looks at the number of genes in the entire organism also associated with that BP.
DAVID then calculates the probability that a random sample from the entire genome (with equal
number of genes from the input list) has an equal or greater proportion of genes associated with
the BP. The BPs are sorted in order of significance (lowest highest p-value) along with their
associated genes. The genes differentially expressed between the two media, listed in [83], was
put into DAVID. Only genes whose BPs related to development and differentiation, proliferation,
cell-cycle, morphology or cell death were retained. In total, 3434 genes were input into DAVID
which output 2288 related to the BPs of interest (set ‘1’ in Figure 2.17).
We selected only genes which act on the core network (i.e., Oct4, Sox2 and Nanog) because only
these would be capable of affecting the dynamics of Nanog, and therefore indirectly pluripotency.
The published data set does not have information on how the genes in it regulate other genes,
therefore a different source is needed to add this information. An updated compendium of mESC
TFs was used called CODEX [85, 127] which contains what genes 40 mESC TFs regulate. CODEX
contained ChiP-seq experiment results to supply this information. From CODEX, a list of 34
genes (set ‘2’ in Figure 2.17) was generated, where each of these genes regulates at least one of
the core factors.
Genes which were both found to be involved in the BPs of interest and also to regulate one
of the core factors (intersection of set ‘1’ and set ‘2’ in Figure 2.17) were considered of interest
to add to the reference model. We identified four genes; Mycn, Rest and Chd7 expressed higher
in Serum+LIF; and Prdm14 expressed higher in 2i+LIF. Mycn, Rest and Prdm14 were found in
previous literature to significantly affect mESC pluripotency [140, 150, 164]. However Chd7 was
found to not be essential for self-renewal and pluripotency [130] and was therefore not included
into the final network.
2.3.3 Gene interaction directions
The three genes found (Mycn, Rest and Prdm14) are known to regulate one of the core factors
(Oct4, Sox2 and Nanog). However, the analysis so far cannot say whether the interactions involve
activations or inhibitions. For this, we used the NIA bank [107], which contains results from
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microarray experiments with 54 different TFs. Out of the six genes in the extended network, four
were in NIAbank: Nanog, Oct4, Sox2 and Mycn.
2.3.4 Medium signalling components and protein-protein interactions
The culture 2i+LIF contains two inhibitors; PD and Chiron. PD is, as in [62], modelled as a
signal which weakens the inhibitory effect of FGF4/Erk signalling on Nanog. However the
reference model ignored the effects of Chiron. Chiron is an inhibitor of GSK3 [7], which in
turn destabilizes β-catenin [59, 161] increasing its degradation (Chiron inhibits GSK3 which
inhibits β-catenin). In effect therefore, Chiron acts as an indirect activator of β-catenin. Two
other important non-transcriptional interactions of this pathway are β-catenin inhibiting Tcf3
and Tcf3 inhibiting the regulation of Oct4-Sox2 on Nanog [158]. Given experimental evidence
that PD alone is unable to sustain mESC clonal propagation [57, 158] and the key role of the
β-catenin pathway in pluripotency and reprogramming of somatic cells [72, 87], we explored
these additional interactions.
2.3.5 Putting it all together
Table 2.2 shows which genes of the extended network regulate each other as found in CODEX,
with a tick indicating that the TF binds to a regulatory region of the corresponding gene. Table
2.3 shows whether the TFs found in NIAbank (Nanog, Oct4, Sox2 and Mycn) activate or inhibit
genes on the full network. Interactions found in NIAbank are present as either an up arrow for
activation or a down arrow for repression.
TF Symbol Extended Network genes acted on
Nanog Oct4 Sox2 Mycn Rest Prdm14
Nanog X X X X X X
Oct4 X X X X X X
Sox2 X X X X X X
Mycn X X X
Rest X X
Prdm14 X X X X X X
Table 2.2: Table showing interactions present in CODEX, indicted by a tick if
one of the TFs of interest binds to the regulatory region of one of the genes in
the GRN. Table is read down then across. KEY: Interactions kept as in
[62]. Interactions present in CODEX but not NIA bank. Interactions
present in NIAbank but not in CODEX.
We kept the core network interactions (between Nanog, Oct4 and Sox2) the same as in the
reference GRN [62] as this has already been demonstrated to reproduce mESC dynamics. We
removed Rex1 because it is only considered an output to the system, and therefore not necessary
to describe Nanog dynamics. Interactions found in CODEX, but not NIAbank were removed as we
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TF Symbol Extended Network genes acted on
Nanog Oct4 Sox2 Mycn Rest Prdm14
Nanog ↓ ↓ ↑ ↑
Oct4 ↓ ↑ ↑ ↓
Sox2 ↓ ↓ ↓ ↓ ↓
Mycn ↓ ↑
Table 2.3: Table showing interactions and directions present in NIA bank.
Table is read down then across, with an up arrow indicating activation of a
GRN gene by a TF and down arrow indicating inhibition. KEY:
Interactions kept as in [62]. Interactions present in CODEX but not
NIA bank. Interactions present in NIAbank but not in CODEX.
do not know whether the interaction is an activation or inhibition. Conversely, interactions found
in NIAbank but not CODEX were included. In the NIAbank Oct4 was found to activate Mycn
and Rest, but Sox2 was found to inhibit them both. Taking Oct4-Sox2 together as a heterodimer,
with one half activating and the other inhibiting, there would be no resulting effect. Therefore no
interaction of Oct4-Sox2 was included on Mycn and Rest.
The additional medium signalling interactions were also added: Chiron’s activation of β-
catenin, modelled as an inhibition of its degradation; the inhibition of Tcf3 by β-catenin, modelled
as an activation of Tcf3’s degradation; and Tcf3 inhibiting the regulation of Oct4-Sox2 on Nanog.
We used a recently published data set [168] to identify interactions of β-catenin with the core
network genes and additional genes found. This data set contains microarray experiment results
finding genes differentially expressed between Chiron (β-catenin activator) and XAV (β-catenin
inhibitor). From this β-catenin was found to inhibit Mycn and Rest. Finally, we added protein
interactions from the literature for a positive feedback loop between Nanog and Rest [140], and
Prdm14 inhibition of Fgf/Erk signalling [101].
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2.3.6 Summary of final network
The complete network is represented in Figure 2.18. In summary:
• The heterodimer Oct4-Sox2 represses Prdm14. It also activates itself and Nanog, the latter
interaction being inhibited by Tcf3.
• Nanog activates itself, Prdm14 and Rest. It also inhibits Mycn.
• Mycn inhibits itself and activates Prdm14.
• Rest activates Nanog and Oct4-Sox2.
• Prdm14 inhibits FGF4/Erk inhibition of Nanog’s auto-activation.
• FGF4/Erk is activated by Oct4-Sox2 and inhibits Nanog’s positive auto-regulation.
• Chiron activates β-catenin, β-catenin inhibits Mycn, Rest and Tcf3; and Tcf3 inhibits the
activation of Nanog by Oct4-Sox2.






























Figure 2.18: Extended GRN. Solid lines are transcriptional interactions,
dashed lines are non-transcriptional interactions. Arrows are activations, flat
headed arrows are inhibitions. Core network is made of Nanog, Oct4 and Sox2.
Mycn, Rest and Prdm14 are the genes added which are differentially expressed
between Serum+LIF and 2i+LIF. FGF4/Erk, Tcf3 and β-catenin are added as
targets of the two inhibitors present in 2i+LIF: PD and Chiron (CH).
Parameters correspond to equations (2.39) to (2.47).
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The equations describing the GRN of Figure 2.18 are given by the following:
p = sp1 · kp1
kp1 + [PR]








(k+ [OS])2 · dO · dS +
s3 · [R]








k2 + [N]2 + p · [E] +
s5 · [OS]
k+ [OS]+ [TC] +
s6 · [R]
k+ [R] −dN · [N]
)




































































+ϕ(0,σT ) · [TC],(2.47)
N=Nanog; OS=Oct4-Sox2; M=Mycn; PR=Prdm14; R = Rest; E=Fgf4/Erk; B=β-catenin; TC=Tcf3.
Maximum transcription rates are denoted by Si, Michaelis–Menten constants by ki, noise amplitude by
σi (via normally distributed noise terms ϕ), degradation rates by di, constant transcription rates by αi
and a time normalization factor of n.
Parameter values for this system can be found in Table 2.6. No noise was added to Fgf/Erk
signalling (equation (2.45)) matching the reference model.
2.3.7 Parameter values and fitting
We used the principles set out in Section 2.2.6 to alter the parameters for desired system be-
haviour. Increasing a maximum transcription rate si can be compensated for by simultaneously
increasing the corresponding degradation rate di. Therefore all degradation rates were fixed to 1,
as in the reference model [62], which decreases the number of parameters that need fitting. All ki
values were fixed except where the system needed more or less sensitivity to retain a comparable
order of magnitude of changing network factors. Parameters si were chosen such that in the
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deterministic model the newly added genes have matching fold-change directions between the
two media as in [83] (see below).
A time normalization factor was included to set the system to the correct time scale. This was
chosen to match the half life of Nanog in the system equations to experimental measurements of
its degradation. We did this by considering only Nanog’s degradation with time normalization





As the degradation terms di were all set to 1, dN is not included here. This differential equation
has a solution given by
(2.49) [N(t)]= C · e−nt,
where C is a constant. The half life is the time at which e−nt = 12 , which is the term




We chose a value of n = 0.005 resulting in the half life of Nanog in the system being 138.63. If the
units of the system are in minutes this is equivalent to 2.31 hours, matching the measured half
life of Nanog in [3] (stated as 2.3 hours). This is applied to all the genes in the system meaning
they all have half-lives set the same as Nanog. As Nanog is the main focus of the system and
having only one time normalization factor keeps the number of parameters to a small number,
this simplification is justified.
We found noise parameters σi by first finding a noise value in serum+LIF for Nanog which
gave a distribution of approximately half NH and half NL (based on Figure 2.16) and setting the
rest of the noise parameters to around half of this value to be consistent with measurements of
Nanog having greater fluctuations [4]. Nanog’s maximum transcription rate s4 was also simul-
taneously altered at this stage to output the desired distribution (based on Figure 2.16). Final
parameter values of the equations in (2.39) to (2.47) can be seen in Table 2.6. Values for PD and
Chiron (CH) are changed depending on which culture conditions are being simulated, both set
at zero for Serum+LIF and increased for 2i+LIF. Two different parameter value sets were used
for simulating 2i+LIF (see Section 2.4.2 for more details); PD and Chiron both set to 2 arbitrary
units (AU) with Nanog transcriptional noise reduced by 20% and PD and Chiron both set to 20 AU.
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The deterministic system for PD, CH=0 AU and PD, CH=2 AU is bistable (see Figures 2.19a
and 2.24a), with two steady-states corresponding to NH and NL. As Nanog is the master pluripo-
tency gene, all the other genes in the deterministic system have concentration levels tied to Nanog,
i.e. each gene has a different deterministic steady-state for NH and NL respectively. For PD,
CH=20 the deterministic system is monostable, with only one steady-state set of concentrations
corresponding to NH. The steady-state concentration values of the newly added genes for NH
and NL cell states and for each of the different PD and CH value scenarios (only NH reported for
PD, CH =20) are shown in Table 2.4.
This is only the steady-state value for a single cell. To estimate concentration levels of the
new genes in the different media, we considered the proportion of cells reported in the literature
expressing NH or NL. In Serum+LIF, around 50% of mESCs have a NL concentration and 50%
NH [3, 4]. The steady-state concentrations of the newly added genes in Serum+LIF was therefore
calculated as
(2.51) Cserum = 0.5 ·SSNH +0.5 ·SSNL,
where Cserum is the calculated concentration in Serum+LIF, SSNH is the steady-state value
corresponding to NH and SSNL is the steady-state value corresponding to NL. In 2i+LIF approx-
imately 90% of cells are in a NH state and 10% in the NL [3, 4]. Concentrations for 2i+LIF were
calculated as
(2.52) C2i = 0.9 ·SSNH +0.1 ·SSNL,
where C2i is the calculated concentration in 2i+LIF. For PD and CH=20, with no NL state, the
values from the PD and CH=2 for NL concentrations were used. Fold change between the two







We simulated the deterministic system, recorded the steady-state values and calculated
the fold change. This was done iteratively until the fold change directions of the deterministic
system best matched the data of [83]. Table 2.5 shows the final concentrations calculated from the
deterministic model in each of the media, and the fold changes between 2i+LIF and Serum+LIF.
The table also shows the reported experimental fold changes; although the actual values differ,
the signs (positive or negative) are the same. Qualitatively, the new genes are reported higher or
lower in Serum+LIF versus 2i+LIF in the deterministic model the same as in the data set.
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Table 2.4: Table showing steady-state concentrations for newly added genes
(deterministic system only). Each gene has a seperate steady-state
corresponding to NH and NL.
Gene Serum+LIF concentration 2i+LIF concentration (PD, CH=2) 2i+LIF concentration (PD, CH=20)
Mycn 69.9 40.0 34.0
Prdm14 24.6 31.6 31.3
Rest 14.4 9.2 2.9
Fold change (PD, CH=2) Fold change (PD, CH=20) Fold change (Data [83])
Mycn -0.81 -1.04 -1.71
Prdm14 0.36 0.35 1.49
Rest -0.65 -2.31 -1.08
Table 2.5: Table showing fold change of deterministic system for newly added
genes, with comparison to fold change data values taken from [83].
2.3.8 Simulation and bifurcation analysis
Numerical solutions of the SDEs were performed using the Euler-Maruyama method implemented
using the MATLAB platform (Mathworks). A total time of 5760 equates to four days of simulation.
Step-size ∆ t of each update step was 0.01, equivalent to 0.6 seconds. Bifurcation analysis (i.e.
numerical continuation) was performed on the deterministic system (no noise) using the software
xppaut.
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sp1 30* s14 20* dM 1#
sp2 30* s15 2* dPR 1#
kp1 5* sb 50* dR 1#
kp2 15* st 20* dE 1#
s1,2 75* α1 1* dB 1#
s3 1* α1 40* dTC 1#
s4 37* k 10 σOS 0.02
s5 2* σN 0.05 (0.04 for PD=CH=2)
s6 0.01* kr 0.05 σM 0.02
s7 10* km 0.05 σPR 0.02
s8 100* kt 10 σR 0.02
s9 20* kb 1 σB 0.02
s10 15* dO 1# σT 0.02
s11 30* dS 1# snb 10*
s12 10* dOS 1# n 0.005
s13 0.1* dN 1#
(* molecules/minute; # 1/minute)
Table 2.6: Table showing parameter values for full network described in
equations (2.39) to (2.47).
2.4 New model behaviour/results
We fitted the model to the distributions of Figure 2.2b, for Serum+LIF and 2i+LIF scenarios
respectively. We altered the parameters s4 and σN such that the proportions of NH and NL
matched between the model and the data. We used a simple threshold to define NH and NL,
with any cell expressing a Nanog level lower than the threshold characterized as NL, and as NH
for greater than the threshold. The threshold value we used was 5, (equivalent to 100.6990 when
referring to simulated distribution results).
2.4.1 Serum+LIF results
For simulating Serum+LIF culture conditions we set the values of PD and Chiron (CH) to 0
AU. We explored the model with continuation analysis on the deterministic system (no noise) to
see the stability of the system. Figure 2.19a shows a continuation of the steady-state of Nanog
against its auto-regulatory rate s4. The blue part of the curve denotes stable steady-state, whilst
the red part is unstable. The points at which a blue curve meet a red curve are Saddle-node
bifurcations. The chosen value of s4 is represented by a dashed black line which intersects a
lower stable steady-state (NL steady-state) and a higher stable steady-state (NH steady-state)
separated by an unstable steady-state. The deterministic system therefore exhibits bistability.
Adding the stochastic elements to the deterministic system (resulting in the full SDE shown
in equations (2.39) to (2.47)) allows it to switch between the NL and NH stable steady-state.
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We simulated the SDE model 10,000 times to represent individual instances of mESCs and
recorded the concentration of the cells after steady-state was reached. This distribution is shown
in Figure 2.19b which shows a bistable distribution of Nanog, matching experimental results
shown in Figure 2.2b of approximately 50% of cells in NH and NL states respectively. Simulated
distribution is shown as a histogram with fitted kernal density (red line), normalized as a
probability density function. We also simulated the SDEs with Serum+LIF parameters 50 times,
each with 1000 individual cells. NH was 49.6±1.5% of the overall populations as compared to the
proportion of NH observed experimentally of 56.2±8% [3, 4].
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Figure 2.19: GRN network results for Serum+LIF parameters (PD=CH=0).
a Continuation of Nanog steady-state in the deterministic system (no noise).
Blue lines are stable steady-states, red line is unstable. The current
transcription rate s4 (black dashed line) intersects a low and a high stable
steady-state, indicating bistability. b Distribution of Nanog’s steady-state
concentration in 10,000 simulated cells, showing approximately 50% of the
cells are in the NL state and 50% in the NH state.
Flow cytometry sorting experiment results from [3] are shown in Figure 2.20b. The authors
measured the proportion of mESCs expressing NH over 4 days, with three different starting
populations: a pure NH population, a pure NL population and a mixed population (unsorted
mESCs). We simulated the SDE model for 4 days, once with starting conditions of all NH and once
with all NL (1000 simulations for each starting state). The simulations shown in Figure 2.20a
correctly match the experimental observations of both sub populations, NH and NL, restoring
bistable distributions within 4 days of culture.
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Figure 2.20: Sorting of cells in Serum+LIF. a Simulation of cells sorting
(PD=CH=0). Two simulations were carried out, one with pure NH cells and the
other with only NL. Over time the distirubtions of each of these starting
populations tended towards the steady-state of approximately 50% NH and
50% NL. b Sorting of Nanog from experimental results, adapted from [3].
VNPH and VNPL are starting populations of pure NH and NL cells respectively.
This qualitavely matches our simulation, with both populations tending
towards the same steady-state distribution.
The concentration of Nanog and Oct4-Sox2 over 15 hours is shown for four representative
single cell simulations in Figure 2.21. Nanog is observed to stochastically fluctuate, whilst Oct4-
Sox2 remains steady. Black dashed line represents threshold value used to separate NH from
NL. This matches experimental single-cell measurements of Nanog in [4], shown in Figure 2.22
(experimental time courses are for Nanog only), which show fluctuations between NH and NL
within circa 15 hours.
38
2.4. NEW MODEL BEHAVIOUR/RESULTS












































































Figure 2.21: Four representative time courses of Nanog and Oct4-Sox2
concentration in four cells over 15 hours for Serum+LIF parameter values (PD,
CH=0). Dashed black line is threshold we used to separate NH and NL cells.
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Figure 2.22: Experimental data (time lapse) of Nanog measured in individual
cells cultured in Serum+LIF, adapted from [4]. Individual cells swap between
NH and NL states within a cell cycle (15 hours). Blank data was from dead
cells or errors in the recording.
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2.4.2 2i+LIF results
For simulating 2i+LIF culture conditions, we considered two different parameter cases. For
the first case considered, the values of PD and Chiron were simultaneously increased until the
distributions matched the desired proportions of approximately 10% of cells expressing NL and
90% NH. The value we set both PD and Chiron to achieve this was 20 AU. Figure 2.23a shows
the continuation of Nanog’s steady-state against its auto-regulatory rate s4, with the dashed
black line denoting its value. Here the deterministic system is fully monostable, shown by the
black dashed line intersecting only the NH state. We ran the SDEs with these 2i+LIF parameter
for 10,000 cells, resulting in the distribution shown in Figure 2.23b. A small population of NL
cells is still present, even though the deterministic system no longer has a NL steady-state.
Even with the deterministic system being fully monostable, the stochasticity of the system is
enough to drive some of the cells to the NL state. Another element of the system attracting cells
towards the NL state is the ghost bottleneck, described in [141]. This is where systems close to
Saddle-node bifurcations have longer transients as the system passes underneath. We simulated
the SDEs with these 2i+LIF parameters (PD, CH=20) 50 times, each with 1000 individual cells.
NH was 87.27±0.99% of the overall populations as compared to the proportion of NH observed
experimentally of 91.1±3.1% [3, 4].
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Figure 2.23: GRN network results for 2i+LIF parameters (PD=CH=20).
a Continuation of Nanog steady-state in the deterministic system (no noise).
Blue lines are stable steady-states, red line is unstable. The current
transcription rate s4 (black dashed line) intersects only the high steady-state,
indicating a shift in the deterministic system towards monostability.
b Distribution of Nanog’s steady-state concentration in 10,000 simulated cells,
showing approximately 90% of the cells in the NH state and 10% in the NL
state.
The second 2i+LIF parameters case we explored is increasing PD and Chiron, but also
decreasing Nanog’s stochastic noise. This is more consistent with experimental results which
measured the number of mRNA molecules per cell showing that the fluctuations of Nanog are
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decreased in 2i+LIF [4]. The specific case we considered here is PD and Chiron equal to 2 and
Nanog’s noise term σN reduced by 20% from 0.05 to 0.04. The continuation of Nanog’s steady-
state against s4 for this 2i+LIF scenario can be seen in Figure 2.24a. The system is still bistable,
though the value of s4 (black dashed line) is now very close to the Saddle-node bifurcation. In
combination with reducing the noise, the SDE model can match the observed distribution of
Nanog in 2i+LIF of approximately 90% expressing NH and 10% NL (Figure 2.24b). We again
simulated the SDEs with these new 2i+LIF parameters (PD, CH=2; noise reduced by 20%) 50
times, each with 1000 individual cells. NH cells were 88.46±1% of the overall populations as
compared to the same proportion of NH observed experimentally of 91.1±3.1% [3, 4]. Therefore
both of these 2i+LIF scenarios give qualitatively the same distributions of Nanog.
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Figure 2.24: GRN network results for 2i+LIF parameters (PD=CH=2, noise
reduced 20% [4]). a Continuation of Nanog steady-state in the deterministic
system (no noise). Blue lines are stable steady-states, red line is unstable. The
current transcription rate s4 (black dashed line) intersects both the high and
low steady-state, though is close to the Saddle-node bifurcation of the low state.
The system is still bistable, though has shifted towards monostability.
b Distribution of Nanog’s steady-state concentration in 10,000 simulated cells,
showing approximately 90% of the cells in the NH state and 10% in the NL
state.
We ran flow cytometry sorting simulations for both 2i+LIF parameter sets, with the SDEs
run for four simulated days with starting populations of pure NH and NL cells (1000 realizations
for each). Figure 2.25a is for PD and Chiron equal to 20, and Figure 2.25b is for PD and Chiron
equalling 2, with Nanog noise reduced 20%. For both 2i+LIF cases the cells tend towards the
steady-state distribution of approximately 90% NH, 10% NL. However, simulated cells for the
first case tend towards this steady-state much faster. Sorting experiments in 2i+LIF have not
been performed, and could inform which case is a better representative of mESCs in 2i+LIF.
Four representative cell time courses of Nanog and Oct4-Sox2 concentration for PD=Chiron=20
scenario are shown in Figure 2.26. Oct4-Sox2 concentration remains stable over the 15 hours,
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Figure 2.25: Sorting of cells in 2i+LIF. a Simulation of cells sorting
(PD=CH=20). Two simulations were carried out, one with pure NH cells and
the other with only NL. Over time the distributions of each of these starting
populations tended towards the steady-state of approximately 90% NH and
10% NL. b Simulation of cells sorting (PD=CH=2 and noise reduced 20%). Over
time the distributions of both starting populations tends towards the stable
steady-state of approximately 90% NH and 10% NL. However they approach
this steady-state slower.
whilst Nanog concentration fluctuates. Black dashed lines represent threshold value used to
separate NH from NL.
Four representative cell time courses of Nanog and Oct4-Sox2 concentration for PD=Chiron=2
and noise reduced 20% scenario are shown in Figure 2.27. Similar to the PD, Chiron=20 case,
cells express stable concentrations of Oct4-Sox2, with fluctuating levels of Nanog. Black dashed
lines represent threshold value used to separate NH from NL. Qualitatively, simulation time
courses in Figures 2.26 and 2.27 match experimental single-cell measurements in Figure 2.28
(experimental time courses are for Nanog only).
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Figure 2.26: Four representative time courses of Nanog and Oct4-Sox2
concentration in four cells over 15 hours for 2i+LIF parameter values (PD,
CH=20). Dashed black line is threshold we used to separate NH and NL cells.
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Figure 2.27: Four representative time courses of Nanog and Oct4-Sox2
concentration in four cells over 15 hours for 2i+LIF parameter values (PD,
CH=2; noise reduced 20%). Dashed black line is threshold we used to separate
NH and NL cells.
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Figure 2.28: Time lapse of Nanog measured in individual cells cultured in
2i+LIF, adapted from [4]. Blank data was from dead cells or errors in the
recording.
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Of note, in 2i+LIF simulation results shown hereafter, the reduced noise parameters were
used. This is to more realistically represent experimental data. Furthermore, distribution plots
are now normalized as % of Max, and only kernal fitting functions are shown.
2.4.3 Gene/molecular pathway deletions
To understand how the newly added genes effect the system stability, we performed 2-parameter
continuations on the variables PD and Chiron. This was for the whole network, and under single
gene deletions. To simulate a gene’s deletion we set all terms contributing towards that gene in
the differential equation system to 0, and the initial concentration of that gene was also set to 0,
ensuring that the gene’s concentration remains at nothing for all time. Figure 2.29 shows the 2-
parameter continuations of the whole network, and upon single gene deletions. We performed this
in xppaut, continuing a Saddle-node bifurcation as found from single parameter continuations.
The area above each respective curve denotes the region of PD and Chiron concentrations for
which the deterministic system is monostable, NH only.

















Figure 2.29: 2-parameter continuations of the Saddle-node from Nanog’s
continuation against PD and Chiron; with the full network, and with gene
deletions. Each curve is a Saddle-node bifurcation, above which the system is
monostable.
For the whole network (Figure 2.29, red line) both inhibitors enable the shift of the system
towards a single NH steady-state, PD via altering Nanog’s positive feedback regulation and
Chiron via strengthening Oct4-Sox2 activation of Nanog (indirectly the same mechanism as in
Figure 2.11). Deletion of Rest (Figure 2.29, black dashed line) does not significantly affect the
systems stability, whilst for Mycn deletion a monostable NH state can only be obtained if PD and
Chiron are further increased (Figure 2.29, blue line). This is due to the indirect regulation of
Mycn on Nanog through Prdm14. The effect is much stronger upon Prdm14 deletion, requiring a
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significant increase of PD and Chiron (Figure 2.29, green line).
The results from the 2-parameter continuations prompted further exploration of the effects of
deleting the newly added genes, especially for Prdm14. We therefore simulated the SDE model,
deleting each of the genes, to see what effect this would have on the steady-state distribution
of Nanog. Upon Rest and Mycn deletion no change in the steady-state distribution of Nanog
was observed (they appear the same as in Figures 2.19b and 2.24b for Serum+LIF and 2i+LIF
parameter values respectively). This shows how important noise is in the system, as the noise is
able to maintain the distributions of Nanog, even with changing of the deterministic steady-states.
However, upon Prdm14 deletion the steady-state distribution of Nanog was significantly changed.
Figure 2.30 shows steady-state distributions of Nanog simulated in 1000 cells with Prdm14
deleted. Figure 2.30a is for Serum+LIF and shows a greater proportion of mESCs expressing
NL, implying a large reduction in pluripotency (compare to Figure 2.19b). For 2i+LIF, shown in
Figure 2.30b, Nanog heterogeneity persists (compare to Figure 2.24b). This is consistent with
experimental results showing that upon Prdm14 deletion mESCs cultured in 2i+LIF display
heterogeneous Nanog expression and defective differentiation potential [164].
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Figure 2.30: Distriubtions of Nanog upon Prdm14 deletion for a Serum+LIF
parameters and b 2i+LIF parameters. Both parameter sets show a significant
increase in the proportion of NL mESCs, indicating a reduction of pluripotency.
To explore what effect β-catenin and Tcf3 have on the stability of the system, we performed
continuations of the steady-state of Nanog against its auto-regulatory rate upon β-catenin
deletion and Tcf3 deletion. When β-catenin is deleted, the system is pushed further into the
bistable regime for both Serum+LIF (Figure 2.31a) and 2i+LIF (Figure 2.31b) as shown by the
dashed black lines; compare to Figures 2.19a and 2.24a respectively.
More pronounced effects are seen for Tcf3 deletion. For Serum+LIF parameters (Figure 2.32a)
the system has shifted entirely into a NH mono stable regime, with a further shift for 2i+LIF
parameters (Figure 2.32b) as compared to Figures 2.19a and 2.24a respectively. This is consistent
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Figure 2.31: Continuations of Nanog steady-state upon β-catenin deletion, in
the deterministic system (no noise). Blue lines are stable steady-states, red line
is unstable. a Serum+LIF parameters. The current transcription rate s4 (black
dashed line) intersects both the high and low steady-state, indicating
bistability. b 2i+LIF parameters. The current transcription rate s4 (black
dashed line) intersects both the high and low steady-state, though has moved
closer to the Saddle-node bifurcation. The system is slightly further into the
bistable regime upon β-catenin deletion.
with experimental results showing that when Tcf3 is inhibited, mESC differentiation is delayed
[165], i.e. the cells are more pluripotent.
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Figure 2.32: Continuations of Nanog steady-state upon Tcf3 deletion.
a Serum+LIF parameters. The current transcription rate s4 (black dashed
line) intersects only the high steady-state. b 2i+LIF parameters. The current
transcription rate s4 (black dashed line) intersects only the high steady-state,
though is further into the monostable regime. Both parameter sets show a
significant shift of the system into the high monostable regime upon Tcf3
deletion.
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2.4.4 Alternative network structures/modifications to the GRN
Nanog has been reported to indirectly activate β-catenin [87], inhibiting Dkk1 which inhibits β-
catenin. This interaction was reported to be important for successfully reprogramming fibroblast
cells (a type of cell that creates the structure for animal tissues) into pluripotent stem cells.
Therefore, we explored this interaction by adding it to the model. For simplicity this was modelled
as a direct activation by Nanog, ignoring the double inhibition through Dkk1. The part of the






















showing the addition of an snb Hill term. Parameter values are in Table 2.6.
Figure 2.33a shows the GRN interaction of the added activation, and Figure 2.33b shows
2-parameter continuations of the new system, as well as without the added interaction for
comparison. This shows that adding this interaction reduces the amount of PD and Chiron (in
































Nanog activation of -cat
Figure 2.33: Added activation of β-catenin by Nanog. a Extended GRN of
Figure 2.18 with added interaction of Nanog on β-catenin. b 2-parameter
continuations of the Saddle-node from Nanog’s continuation against PD and
Chiron; with original network, and with added activation. Each respective
curve is a Saddle-node bifurcation, above which the system is monostable.
We ran the SDE model for the original system and with the added activation shown in Figure
2.33a to compare steady-state distributions of both Nanog and β-catenin. Figure 2.34a shows
the steady-state distribution of Nanog, without Nanog activating β-catenin and for Serum+LIF
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parameter values. Figure 2.34b shows the steady-state distribution of β-catenin under the
same conditions. The steady-state of Nanog is the same as in 2.19b demonstrating Nanog’s
heterogeneity with a bimodel distribution. With no activation by Nanog, β-catenin’s steady-state
distribution is monostable.
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Figure 2.34: Distributions of Nanog (a) and β-catenin (b) with no activation
of β-catenin by Nanog and using Serum+LIF parameters. Approximately 50%
of the mESCs are in a NH state, and 50% NL. The distribution of β-catenin is
monostable.
When Nanog activating β-catenin is added the steady-state of Nanog is unchanged, as shown
in Figure 2.35a (compare to Figure 2.34a). This again demonstrates how the system can be more
sensitive to noise than to stability of the deterministic system, as the 2-parameter continuation
shows the deterministic system is affected, but this does not impact on the SDE model when noise
is added. With the added activation the steady-state distribution of β-catenin is now bimodel,
as shown in Figure 2.35b. The difference between the high β-catenin and low β-catenin state is
smaller than for Nanog, correctly matching results as reported in [87].
Figure 2.36a shows the steady-state distribution of Nanog, without Nanog activating β-
catenin and for 2i+LIF parameter values. Figure 2.36b shows the steady-state distribution of
β-catenin under the same conditions. The steady-state of Nanog is the same as in 2.24b with
approximately 90% of cells in NH and 10% in NL. With no activation by Nanog, β-catenin has
a monostable distribution and the concentration value has been increased as compared to in
Serum+LIF (compare to Figure 2.34b) due to β-catenin being directly activated by Chiron.
With 2i+LIF parameters, and now including Nanog activation on β-catenin, Nanog’s steady-
state distribution remains unaffected as shown in Figure 2.37a (compare to Figure 2.36a).
β-catenin now has a bimodel distribution, with more cells in a high β-catenin state as compared
to in Serum+LIF (Figure 2.35b).
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Figure 2.35: Distributions of Nanog (a) and β-catenin (b) with activation of
β-catenin by Nanog and using Serum+LIF parameters. Approximately 50% of
the mESCs are in a NH state, and 50% NL. The distribution of β-catenin is
now bistable with just over half of the mESCs in a β-catenin high state.
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Figure 2.36: Distributions of Nanog (a) and β-catenin (b) with no activation
of β-catenin by Nanog and using 2i+LIF parameters. Approximately 90% of the
mESCs are in a NH state, and 10% NL. The distribution of β-catenin is
monostable, and at a higher level than for Serum+LIF.
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Figure 2.37: Distributions of Nanog (a) and β-catenin (b) with activation of
β-catenin by Nanog and using 2i+LIF parameters. Approximately 90% of the
mESCs are in a NH state, and 10% NL. The distribution of β-catenin is now
bistable with approximately 90% of the cells in a β-catenin high state.
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The interaction between β-catenin and Mycn has conflicting results in different experimental
studies. The data set we used predicted β-catenin to inhibit Mycn. However a different study
reported a positive feedback loop between Mycn and β-catenin [40]. Therefore we considered both
the case of no regulation of β-catenin on Mycn, and the case of β-catenin activating Mycn. The





















where the s9 Hill term has been removed. Parameter values are in Table 2.6
Figure 2.38a shows a schematic for the deletion of the regulation of β-catenin on Mycn. Figure
2.38b shows a 2-parameter continuation on PD and Chiron, where the area above the curve
denotes the parameter region for which the system is monostable (NH only). Comparing to
































Figure 2.38: β-catenin interaction on Mycn removed. a Extended GRN of
Figure 2.18 with interaction of β-catenin on Mycn removed. b 2-parameter
continuation of the Saddle-node from Nanog’s continuation against PD and
Chiron, above the curve the system is monostable.
Continuing the steady-state of Nanog against its auto-regulatory rate s4 when deleting this
interaction resulted in no change to the stability of the deterministic system, for both medium
parameters, (compare Figure 2.39a to 2.19a for Serum+LIF and 2.40a to 2.24a for 2i+LIF). The
same lack of change is observed when simulating the full SDE, resulting in the same distributions
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of approximately half NH and NL in Serum+LIF (compare Figure 2.39b to 2.19b for Serum+LIF)
and approximately 90% NH, 10% NL in 2i+LIF (compare Figure 2.40b to 2.24b for 2i+LIF).
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Figure 2.39: β-catenin interaction on Mycn removed results for Serum+LIF
parameters. a Continuation of Nanog steady-state in the deterministic system
(no noise). Blue lines are stable steady-states, red line is unstable. The current
transcription rate s4 (black dahsed line) intersects both the NH and NL
steady-state, indicating bistability. b Distribution of Nanog’s steady-state
concentration, showing approximately 50% of the cells in the NH state and
50% in the NL state.
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Figure 2.40: β-catenin interaction on Mycn removed results for 2i+LIF
parameters. a Continuation of Nanog steady-state in the deterministic system
(no noise). Blue lines are stable steady-states, red line is unstable. The current
transcription rate s4 (black dashed line) intersects both the NH and NL
steady-state, though has shifted nearer to the Saddle-node bifurcation, and to
the NH monostable regime. b Distribution of Nanog’s steady-state
concentration, showing approximately 90% of the cells in the NH state and
10% in the NL state.
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For considering β-catenin activating Mycn, the part of the main GRN equations altered to























showing that the s9 Hill term has been changed to an activation. Parameter values are in Table
2.6. This interaction is shown schematically in Figure 2.41a. Figure 2.41b shows a 2-parameter
continuation on PD and Chiron, where the area above the curve again denotes the values of PD
and Chiron for which the system is monostable (NH only). Comparing to Figure 2.29 (Original,































Figure 2.41: β-catenin interaction on Mycn changed from inhibition to
activation. a Extended GRN of Figure 2.18 with interaction of β-catenin on
Mycn changed to activation. b 2-parameter continuation of the Saddle-node
from Nanog’s continuation against PD and Chiron. Above the curve the system
is monostable.
Continuations of Nanog’s steady-state against its auto-regulatory rate s4 and simulations of
the SDEs show no effect from the change of this interaction to an activation. Figure 2.42a and
2.43a look the same as to the original network shown in Figure 2.19a and 2.24a (for Serum+LIF
and 2i+LIF respectively) and Figure 2.42b and 2.43b show the same distributions of Nanog at
steady-state in Serum+LIF and 2i+LIF (compare to Figures 2.19b and 2.24b).
Therefore this interaction has been demonstrated to be unimportant for the pluripotency of
the simulated system, and was kept as originally found in the database of [168].
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Figure 2.42: β-catenin interaction on Mycn changed to activation results for
Serum+LIF parameters. a Continuation of Nanog steady-state in the
deterministic system (no noise). Blue lines are stable steady-states, red line is
unstable. The current transcription rate s4 (black dashed line) intersects both
the NH and NL steady-state, indicating bistability. b Distribution of Nanog’s
steady-state concentration, showing approximately 50% of the cells in the NH
state and 50% in the NL state.
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Figure 2.43: β-catenin interaction on Mycn changed to activation results for
2i+LIF parameters. a Continuation of Nanog steady-state in the deterministic
system (no noise). Blue lines are stable steady-states, red line is unstable. The
current transcription rate s4 (black dashed line) intersects both the NH and
NL steady-state, though has shifted nearer to the Saddle-node bifurcation, and
to the NH monostable regime. b Distribution of Nanog’s steady-state
concentration, showing approximately 90% of the cells in the NH state and
10% in the NL state.
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2.4.5 Alternative simpler networks capable of reproducing bistability in
Nanog
The deterministic (no noise) bistability of Nanog is caused by an activation feedback (positive
auto-regulatory loop), as shown in Section 2.2.5. Reduced networks which keep a positive feedback
loop can still recapitulate bistability, even if not directly Nanog activating itself. We wanted to
explore which are the key interactions and feedbacks that cause bistability by looking at three
different simplified networks with different positive feedback loops established within them. Only
continuations of Nanog’s steady-state were performed as they are sufficient to show that the
respective system is capable of bistable behaviour. The first simplified network we considered is
illustrated in Figure 2.44, comprised of the core factors Nanog, Oct4 and Sox2 with an Fgf4/Erk















Figure 2.44: Simplified GRN retaining Nanog auto-activation. Solid lines are
transcriptional interactions, dashed lines are non-transcriptional interactions.
Arrows are activations, flat headed arrows are inhibitions. Core network is
made of Nanog, Oct4 and Sox2. FGF4/Erk, Tcf3 and β-catenin are added as
targets of the two inhibitors present in 2i+LIF: PD and Chiron (CH).
Parameters correspond to equations (2.57) to (2.62).
The equations for the first simplified case of Figure 2.44 are given by
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k2 + [N]2 + p · [E] +
s3 · [OS]



































N=Nanog; OS=Oct4-Sox2; E=Fgf4/Erk; B=β-catenin; TC=Tcf3. Maximum transcription rates are denoted
by Si, Michaelis–Menten constants by ki, degradation rates by di, constant transcription rates by αi and
a time normalization factor of n.
Parameter values for this system can be found in Table 2.7.
sp 35* α2 40* dPR 1#
kp 25 k 10 dR 1#
s1,2 75* kt 10 dE 1#
s3 2* kb 1 dB 1#
s4 37* dO 1# dTC 1#
s5 2* dS 1# n 0.005
sb 50* dOS 1#
st 20* dN 1#
α1 1* dm 1#
(* molecules/minute; # 1/minute)
Table 2.7: Table showing parameter values for GRN of Figure 2.44, described
by equations (2.57) to (2.62).
Continuations of the steady-state of Nanog against its auto-regulatory rate s4 can be seen in
Figure 2.45. When simulating the Serum+LIF scenario (PD, CH=0) as shown in Figure 2.45a, the
current value of s4 (black dashed line) intersects through the NL steady-state, the NH steady-
state and the unstable steady-state separating them. For 2i+LIF (PD, CH=2) the continuation
curve in Figure 2.45b has shifted such that the current value of s4 (black dashed line) is right
on top of the Saddle-node bifurcation. This suggests that Nanog auto-activation is sufficient to
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explain the bistable behaviour of Nanog in mESCs, and inclusion of inhibitors is able to alter the
stability of the system.
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Figure 2.45: Continuation results for GRN of Figure 2.44. Continuation is of
Nanog steady-state; blue lines are stable steady-states, red line is unstable.
a Serum+LIF. The current transcription rate s4 (black dashed line) intersects
both the NH and NL steady-state, indicating bistability. b 2i+LIF. The current
transcription rate s4 (black dashed line) intersects both the NH and NL
steady-state, though has shifted nearer to the Saddle-node bifurcation, and to
the NH monostable regime.
The NIA bank analysis we performed when building the extended network showed Nanog to
be a direct inhibitor of its own transcription (see Table 2.3). This result is also reported in two
independent studies [45, 102]. We therefore explored whether other interactions present in the
network could give rise to positive feedback loops capable of reproducing bistability in the steady-
state of Nanog, even when changing Nanog’s auto-activation into an auto-inhibition. Figure 2.46
shows a GRN for the core factors, with Nanog’s auto-activation changed to an inhibition. We
additionally added an extra interaction of Nanog activating β-catenin, as in Figure 2.33a. An
indirect positive feedback loop is established through β-catenin and Tcf3.
The equations for this system are shown in (2.63) to (2.68) with parameter values in Table
2.8;
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Figure 2.46: Simplified GRN with Nanog auto-inhibition and activation of
β-catenin by Nanog. Solid lines are transcriptional interactions, dashed lines
are non-transcriptional interactions. Arrows are activations, flat headed arrows
are inhibitions. Core network is made of Nanog, Oct4 and Sox2. FGF4/Erk,
Tcf3 and β-catenin are added as targets of the two inhibitors present in 2i+LIF:
PD and Chiron (CH). Parameters correspond to equations (2.63) to (2.68).

































α1 + snb · [N]
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N=Nanog; OS=Oct4-Sox2; M=Mycn; PR=Prdm14; R = Rest; E=Fgf4/Erk; B=β-catenin; TC=Tcf3.
Maximum transcription rates are denoted by Si, Michaelis–Menten constants by ki, degradation rates by
di, constant transcription rates by αi and a time normalization factor of n.
Continuations of Nanog’s steady-state against its auto-inhibitory rate s4 can be seen in Figure
2.47. In Serum+LIF (PD, CH=0) the system is bistable, with the black dashed line in Figure
2.47a intersecting two stable steady-states. Increasing the values of the inhibitors for 2i+LIF (PD,
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sp 35* α1 1* dM 1#
kp 5 α2 40 dPR 1#
s1,2 75* k 10 dR 1#
s3 35* kt 0.15 dE 1#
s4 5* kb 250 dB 1#
s5 2* dO 1# dTC 1#
sb 50* dS 1# n 0.005
st 15* dOS 1#
snb 10* dN 1#
(* molecules/minute; # 1/minute)
Table 2.8: Table showing parameter values for GRN of Figure 2.46, described
by equations (2.63) to (2.68).
CH=2) shifts the system further towards the NH state, as in 2.47b. For this system to exhibit
bistability the non linearity of the system had to be increased (Hill coefficients of 3 for both snb
and st Hill terms) and the sensitivity to changing levels of β-catenin had to be increased by
having a low Michaelis–Menten constant for its respective Hill term (kt in st Hill term). This
shows that even when considering Nanog’s auto-regulation as an inhibition, an indirect positive
feedback loop through β-catenin is able to produce bistability.
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Figure 2.47: Continuation results for GRN of Figure 2.46. Continuation is of
Nanog steady-state; blue lines are stable steady-states, red line is unstable.
a Serum+LIF. The current transcription rate s4 (black dashed line) intersects
both the NH and NL steady-state, indicating bistbility. b 2i+LIF. The current
transcription rate s4 (black dashed line) intersects both the NH and NL
steady-state, though has shifted nearer to the Saddle-node bifurcation, and to
the NH monostable regime.
The final simplified network we looked at also took Nanog’s auto regulation as an inhibition
but neglected Nanog’s activation of β-catenin. A different positive feedback loop is established
through an interaction present in the extended network: Nanog activating Rest, reciprocally
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activating Nanog back. The simplified network considered can be seen in Figure 2.48, described



















Figure 2.48: Simplified GRN with Nanog auto-inhibition and activation of an
additional gene ("A", E.g. Rest) by Nanog, which in turn activates Nanog back.
Solid lines are transcriptional interactions, dashed lines are
non-transcriptional interactions. Arrows are activations, flat headed arrows
are inhibitions. Core network is made of Nanog, Oct4 and Sox2. FGF4/Erk,
Tcf3 and β-catenin are added as targets of the two inhibitors present in 2i+LIF:
PD and Chiron (CH). Parameters correspond to equations (2.69) to (2.75).
The interactions of this network are modelled by:
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N=Nanog; OS=Oct4-Sox2; R = Rest; E=Fgf4/Erk; B=β-catenin; TC=Tcf3. Maximum transcription rates
are denoted by Si, Michaelis–Menten constants by ki, degradation rates by di, constant transcription
rates by αi and a time normalization factor of n.
Parameter values for this system can be found in Table 2.9.
sp 35* st 20* dOS 1#
kp 10 α1 1* dN 1#
s1,2 75* α2 40* dM 1#
s3 6* k 10 dPR 1#
s4 1* kn 45 dR 1#
s5 2* kt 6 dE 1#
s6 48* kb 1 dB 1#
s7 50* dO 1# dTC 1#
sb 50* dS 1# n 0.005
(* molecules/minute; # 1/minute)
Table 2.9: Table showing parameter values for GRN of Figure 2.48, described
by equations (2.69) to (2.75).
Continuations of Nanog’s steady-state against the activation rate of Rest on Nanog, s6, are
shown in Figure 2.49. In Serum+LIF the deterministic system is bistable, with the chosen value
of s6 (dashed black line) intersecting both the NH and NL steady-states. When PD and Chiron
are introduced into the system, the 2i+LIF results show the system shifted further to the NH
steady-state with the value of s6 (dashed black line) much closer to the Saddle-node bifurcation.
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Figure 2.49: Continuation results for GRN of Figure 2.48. Continuation is of
Nanog steady-state; blue lines are stable steady-states, red line is unstable.
a Serum+LIF. The current transcription rate s4 (black dashed line) intersects
both the NH and NL steady-state, indicating bistbility. b 2i+LIF. The current
transcription rate s4 (black dashed line) intersects both the NH and NL
steady-state, though has shifted nearer to the Saddle-node bifurcation, and to
the NH monostable regime.
2.4.6 Agent-based model
All analysis in this section was performed by the following collaborators: Daniel Ward and Martin
Homer from the Department of Engineering Mathematics in Bristol; Elisa Pedone from Engi-
neering Mathematics and the school of Cellular and Molecular Medicine in Bristol; Alexander G.
Fletcher from the School of Mathematics and Statistics and the Bateson centre in the University
of Sheffield; and Lucia Marucci from the Department of Engineering Mathematics, the School of
Cellular and Molecular Medicine and BrisSynBio of the University of Bristol.
All the previous modelling and analysis ignored physical cell to cell interactions and the
cell-cycle. The cell-cycle is composed of different phases, namely G1, S and G2, through which a
cell progresses before dividing. More succinctly, the length of the cell-cycle is the time it takes for
a cell to divide. Three studies disagreed in their results of how 2i+LIF and Serum+LIF affect the
cell-cycle. One [26] reported a quicker cell-cycle time in 2i+LIF, another [71] reported a slower
cell-cycle time in 2i+LIF, and a third [145] reported no difference between the two media. We
therefore performed our own culturing of mESCs in Serum+LIF and 2i+LIF, measuring how the
rate of proliferation varies between the two media. We found a significantly slower proliferation
rate in 2i+LIF as compared to Serum+LIF, as shown in Figure 2.50.
An agent based model was developed to match the progression of the cell-cycle within the
two media. The was created in the Chaste modelling framework [93, 110], an extensive library
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in C++ which contains tools for agent based modelling of cell/tissue cultures. Each cell agent
contains its own realization of the GRN, upon which gene concentration levels within affect
cell-cycle and cell states. The cell-cycle time, derived from the GRN, is then fed into the model
that describes physical interactions between neighbouring cells (see Figure 2.55 for snapshot
of physical agent system). Two different genes within the GRN are candidates from which the
cell-cycle can be based on, Nanog and Mycn. Nanog levels have been shown to correlate positively
with proliferation rate (at least in Serum+LIF) [61]. The Myc family of TFs (includes Myc and
Mycn) has been shown to positively regulate cell growth proliferation in various cell types [30].
When using Nanog to define a mESCs cell-cycle time, cells are classified as either Nanog high
(NH) or Nanog low (NL), using a threshold level to separate them. The same approach is used
when using Mycn for the cell-cycle, except mESCs are classified as Mycn high (MH) or Mycn
low (ML). A mESC classified as NH will progress through the cell-cycle faster than for NL and
will therefore have a shorter cell-cycle duration, with the same behaviour for MH cells versus
ML cells. Distributions of cell-cycle times were created for NH, NL, MH and ML, where the
time it takes for an agent to divide would be a variable randomly drawn from the distribution
corresponding to its state (e.g. NH state). The cell-cycle distributions were altered to match the
proliferation rate of the simulated cell agents with that of the real world mESCs we measured
experimentally.
We first used Nanog to couple gene expression and cell-cycle duration as in [61], where
simulated mESC agents had their cell-cycle times altered to match the proliferation we measured
in Serum+LIF. With the allocated cell-cycle times (CCNH = 8.5±1h and CCNL = 13.5±1h, where
CCNH and CCNL are cell-cycle times for NH and NL cells respectively), the simulated Serum+LIF
proliferation rate had a root-mean squared error (RMSE) of 2.35 compared to the data, as shown
in Figure 2.50a (blue line). Distributions of Nanog concentration in the population of cells showed
approximately 50% in NL and 50% in NH, consistent with the SDE model and experimental data
(compare Figure 2.51a to 2.19b and 2.2b). Using the cell-cycle times fitted to Serum+LIF but with
2i+LIF parameters (PD=2, CH=2, Nanog noise reduced 20%) resulted in a distribution of Nanog
concentrations consistent with the SDE model and experimental data of approximately 90% NH
and 10% NL (compare Figure 2.51b to 2.24b and 2.2b). However, the proliferation rate of mESCs
in the agent model was increased in 2i+LIF, in direct contrast to experiment (red line in Figure
2.50a) with a RMSE of 22.59.
We then fitted cell-cycle times to the 2i+LIF experimental rates by increasing the cell-cycle
times (CCNH = 13.175±1h and CCNL = 20.925±1h) resulting in a RMSE of 1.07 between the
model and 2i+LIF data shown in Figure 2.50b (red line). However these times were poor at
predicting the growth rate in Serum+LIF (blue line in Figure 2.50b) with a RMSE of 11.01. This
shows that coupling the cell-cycle to Nanog is unable to reproduce the experimental proliferation
rates observed between the two media.
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Figure 2.50: Comparison of experimental and model simulated fold change in
proliferation dynamics of mESCs in the two different media. In the model, the
cell-cycle is coupled to Nanog levels. a Serum+LIF data were fitted, and 2i+LIF
behaviour predicted by the model. b 2i+LIF data were fitted, and Serum+LIF
behaviour predicted by the model.
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Figure 2.51: Nanog steady-state distribution, with cell-cycle coupled to Nanog
concentration. a Serum+LIF parameters; approximately 50% of the mESCs
are in a NH state and 50% in the NL. b 2i+LIF; approximately 90% of the
mESCs are in a NH state and 10% in the NL.
The same procedure was carried out again, coupling cell-cycle to Mycn instead of Nanog.
Proliferation was fitted to the measured rate in Serum+LIF, with the cell-cycle time distributions
(CCMH = 8.5±1h and CCML = 15±1h, where CCMH and CCML are cell-cycle times for MH
and ML cells respectively) giving a RMSE of 2.02. The distribution of Nanog concentration
within the cell population again matched the SDE model of around 50% NH and 50% NL cells
(compare Figure 2.53a to 2.19b and 2.2b). Using these cell-cycle times, but simulating 2i+LIF
gave a distribution of Nanog matching the SDE model and experimental data of approximately
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90% NH, 10% NL (Compare Figure 2.53b to 2.24b and 2.2b). The proliferation profile using the
Serum+LIF fitted cell-cycle times with 2i+LIF medium parameters gave a much better fit to the
measured rate in 2i+LIF (red line in Figure 2.52a) with a RMSE of 3.08 (compared to 22.59 with
the Nanog cell-cycle). The growth rate was then fitted to the 2i+LIF proliferation data with the
fitted cell-cycle times (CCMH = 9.5±1h and CCML = 16±1h) resulting in a RMSE of 1.33 (red
line in Figure 2.52b). Using these times with Serum+LIF parameters gave a better fit than before
(RMSE of 4.41 compared to 11.01), and the qualitatively correct change in proliferation of mESCs
dividing faster in Serum+LIF than in 2i+LIF (blue line in Figure 2.52b).
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Figure 2.52: Comparison of experimental and model simulated fold change in
proliferation dynamics of mESCs in the two different media. In the model, the
cell-cycle is coupled to Mycn levels. a Serum+LIF data were fitted, and 2i+LIF
behaviour predicted by the model. b 2i+LIF data were fitted, and Serum+LIF
behaviour predicted by the model.
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Figure 2.53: Nanog steady-state distribution, with cell-cycle coupled to Mycn
concentration. a Serum+LIF; approximately 50% of the mESCs are in a NH
state and 50% in the NL. b 2i+LIF; approximately 90% of the mESCs are in a
NH state and 10% in the NL.
Sorting experiments were simulated with the agent model for the Mycn dependant cell-cycle
model, as shown in Figure 2.54. The agent based model shows the same cell dynamics upon
sorting as the SDE model, comparing Figure 2.54a to 2.20a for Serum+LIF and 2.54b to 2.25b for
2i+LIF.
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Figure 2.54: Agents sorted by Nanog concentration into NH and NL,
re-establishing steady-state concentrations (Mycn dependent cell-cycle).
Shaded areas represent standard error. a Sorting with Serum+LIF parameters,
with agents tending towards a population with approximately 50% NH and
50% NL. b Sorting with 2i+LIF parameters, agents tend towards
approximately 90% NH and 10% NL.
Snapshot of agents used to model mESCs can be seen in Figure 2.55. Starting agent config-
urations are in Figures 2.55a and 2.55c for Nanog and Mycn respectively, and snapshots after
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Figure 2.55: Snapshot of cell agents with colour representing gene
concentration. a,c Start of simulation for Nanog and Mycn respectively.
b,d Mid way through simulation for Nanog and Mycn respectively.
2.5 Discussion
We derived a new GRN, describing the interactions between genes governing mESC pluripotency
behaviour. We performed both deterministic and stochastic simulations of our GRN, and were
able to reproduce experimental data. Furthermore, an agent based extension to the GRN was
developed to account for mESC cell-cycle.
Our network reproduced distributions of the key pluripotency gene Nanog, and how the
distribution changes when cultured in serum+LIF compared to in 2i+LIF. We correctly repro-
duce ND cell distributions with our model, showing greater heterogeneity in Serum+LIF, and a
persistent sub-population of NL cells in 2i+LIF. The GRN reproduces sorting data as obtained
from flow cytometry sorting and individual cell time courses of Nanog match observed time
courses, stochastically fluctuating between high and low states within a single cell-cycle. Our
numerical continuation analysis on PD and Chiron show that both contribute to the regulation of
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the stability and dynamics of the system. Furthermore, our gene deletion simulations correctly
predict a reduction in pluripotency upon Prdm14 and increase in pluripotency for Tcf3 deletion.
We demonstrated via the simpler topologies results that the newly added genes to the network,
Mycn, Prdm14 and Rest, were not necessary to reproduce Nanog dynamics. However, these newly
added genes were each found to have a key role within the GRN. Prdm14 maintains the correct
proportion of NH and NL mESCs via its interaction through the FGF4/Erk pathway, as shown
with the Prdm14 deletion results. Rest is a candidate that can supply a positive feedback on
Nanog, even in the case of Nanog’s direct regulation being an inhibition, as shown by the reduced
network results. The agent based model results indicate Mycn as a key gene regulating mESC
proliferation, as we show that it was not possible to account for mESC proliferation dynamics
when coupling Nanog to the cell-cycle, as suggested by a previous model [61].
The two main features of our GRN giving rise to a heterogeneous distribution of Nanog are;
a positive feedback loop on Nanog giving it deterministic bistability, and noise which allows
individual cells to switch between the two steady-states. We show there is an interplay between
noise and determinism, and that the system can be very robust to changes in the deterministic
model. Many of our results show changes to the deterministic model make little observable
difference to the full SDE realization with those parameters.
Experimental evidence, and our own NIA analysis, suggests that Nanog’s direct auto regula-
tion is an inhibition not an activation. We show that other indirect positive feedback loops can
be generated within our GRN, even in the case of considering Nanog’s direct regulation as an
inhibition. If these indirect positive feedbacks are not considered, another alternative mechanism
that could explain the heterogeneity of Nanog, would be a negative feedback on Nanog giving
rise to a limit cycle alternating between the two steady-states. However, a published model
incorporating a negative feedback loop on Nanog resulting in a limit cycle [52] was not consistent
with recent experimental results based on mESC single-cell resolution data [139]. Therefore, with
the current evidence, a positive feedback with added transcriptional noise is the better modelling
approach.
The main limitation of our model is the complexity of these GRNs; there are thousands of
genes and molecular substrates all interacting with each other and we only look at a handful of
factors. Another limitation is that many of the parameters of the system were not fitted to data,
only qualitatively reproducing behaviour, and could be considered arbitrary. Even with these
limitations, our analysis still provides useful insights into the stability and dynamic behaviour of











BACKGROUND OF FMRI ANALYSIS: A SYSTEMATIC REVIEW OF
RESTING-STATE STUDIES IN MULTIPLE SCLEROSIS
This chapter gives the background and motivation for the work carried out in Chapter4 in the form of a systematic review. A systematic review is a type of literature reviewgenerally used for clinical practise, in which one follows explicit and transparent methods
in order to minimise bias. The process was written up prior to the review in a protocol which is
publicly published [54]. The review follows a standard set of stages set out in the protocol, and as
such it is repeatable and transparent. Two reviewers were mainly involved in this review; myself
as main reviewer and Christelle van Anterwerpen of CRICBristol as second reviewer.
3.1 Introduction
Multiple Sclerosis (MS) is characterised as an inflammatory demyelinating disease of the central
nervous system (CNS), which results in widespread plaques in the brain and spinal cord and
results in demyelination of the axons. MS is a common neurological disorder and leading cause of
disability in young adults. It has considerable negative impact on quality of life and its prevalence
around the world is increasing [17]. MS represents a significant health burden both financially
and socially. Mackenzie et al. 2013 [80] estimated that the cost of MS in the UK in 2010 alone
was approximately 3.8 billion euros. In 2010 the prevalence of MS was 258.8 per 100,000 in
women and 113.3 per 100,000 in men [80]. The pathology of MS is diverse with both physical and
neuropsychiatric symptoms [44]. Two of the most common symptoms are fatigue and cognitive
dysfunction, with over 92% of patients reporting fatigue as one of the most debilitating effects of
the disease [16], and 45-65% presenting with cognitive deficits on clinical assessments [34].
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Early studies suggested that cognitive impairments were directly related to neurological
changes [144]. However more recent research suggests only a weak relationship between the
changes in the brain and cognitive impairments in MS [81]. One possible explanation for these
results may be due to neuroplasticity, i.e., the ability to reorganise and form new connections
in the brain. Neuroplasticity may allow individuals with MS to maintain normal performance
despite the accumulating tissue damage. Understanding the mechanisms as to how the brain
compensates and reacts to this damage is an important first step for future clinical applications.
Understanding the neuroplasticity may provide insights into the neural mechanisms in MS,
and may even lead to an objective measurement to determine the effectiveness of treatments or
therapies.
MS is comprised of several phenotypes. Approximately 80% of patients manifest a relapse-
remitting course, relapse-remitting MS (RRMS), which after several years can be succeeded by a
secondary progressive phase, secondary progressive MS (SPMS). In a minority of patients the
relapse-remitting stage does not manifest and the progressive stage occurs at onset, primary
progressive MS (PPMS) [15, 74]. Early studies of MS suggested that it was a disease related
to white matter atrophy and that grey matter lesions were rarely seen [117]. More recent stud-
ies have established that brain atrophy affects both the white matter and grey matter in MS
[73, 111, 121, 169]. However, structural imaging studies are not able to investigate how this
damage affects the function of the brain. An indirect measure of brain activity is functional
magnetic resonance imaging (fMRI). This is a non-invasive method of measuring brain activity,
focusing on blood flow through the brain via the blood oxygen level dependent (BOLD) signal.
The BOLD signal of a region is an indirect measure of neuronal activity in that region, as a more
active region of the brain requires more oxygenated blood. fMRI is most commonly used to see
which regions of the brain are activated by a certain task or stimuli. In MS specifically, multiple
studies have used fMRI to investigate cognitive impairment in domains such as memory and
attention [14, 81, 123, 156] as well as establish possible neural correlates of fatigue [82]. Recently,
there has been a growing interest into applying fMRI at rest, termed resting-state fMRI (rs-fRMI)
[119]. This technique measures spontaneous fluctuations of the BOLD signal and an associated
measure of the baseline functional organisation of the brain called functional connectivity (FC).
Changes in measured FC between MS and healthy controls (HC) can be used as evidence for
neuroplasticity in MS.
The main focus of this review was to investigate the evidence of neuroplasticity in MS from
rs-fMRI data. Further aims were to evaluate the different data analysis techniques and methods
applied to rs-fMRI, to assess the advantages and disadvantages of the individual analysis
techniques and to understand the implications of MS on FC and neuroplasticity.
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3.2 Materials and methods
We searched Embase, Medline, PsychINFO and Scopus from the first year of successful fMRI
(1991) up until the start date of the review (21 March 2017). Search terms were grouped into four
categories: MS terms, fMRI terms, resting-state terms and neuroplasticity terms. Multiple words
were searched for in each category and the union of studies found under a specific term formed a
group. See Table 3.1 for the search words used. Articles of interest were in the intersection of all








Figure 3.1: Schematic of search term groups. Terms related to a group were
searched for, and the union of results formed the respective group.
MS terms fMRI terms Resting-state terms Neuroplasticity terms
ms fmri resting state neuroplasticity
multiple sclerosis f mri functional connectivity neuro plasticity
rrms functional mri functional connectivity network neural plasticity
rr ms functional mr imaging resting state network brain plasticity
relapsing remitting ms functional magnetic resonance imaging resting state functional connectivity neuro reorganisation
relapsing remitting multiple sclerosis bold resting state connectivity neural reorganisation
spms blood oxygen level dependent resting state fmri brain reorganisation
sp ms rs fmri neuro reorganization
secondary progressive ms rsfmri neural reorganization
secondary progressive multiple sclerosis default mode network brain reorganization
ppms dmn neuro compensation
pp ms rsn neural compensation
primary progressive ms brain compensation
primary progressive multiple sclerosis neuro compensatory
cis neural compensatory
clinically isolated syndrome brain compensatory
Table 3.1: Search terms used, in their respective term group.
Inclusion criteria were: resting-state fMRI studies of MS patients, where MS is defined as
per National Institute for Health and Care Excellence (NICE) guidelines [2], Centers for Disease
75
CHAPTER 3. BACKGROUND OF FMRI ANALYSIS: A SYSTEMATIC REVIEW OF
RESTING-STATE STUDIES IN MULTIPLE SCLEROSIS
Control and Prevention (CDC) criteria [108], World Health Organisation [17] or the McDonald
criteria [89, 115, 116]. Additional inclusion criteria were resting-state fMRI studies of MS alone,
or MS in comparison to healthy or other clinical populations. Exclusion criteria were: studies
older than the first published paper defining the BOLD mechanism in 1991 and after the start
date of review, 21 March 2017, and task-based fMRI, i.e. studies with no pure resting-state
acquisition.
Two reviewers (SG, CVA) independently assessed the articles of interest for eligibility using
the tool Covidence [1], where disagreements were resolved via discussion and consensus. We
assessed the quality of studies in terms of risk of bias using seven criteria (Table 3.9): research
objective, recruitment procedure, inclusion/exclusion criteria, population demographics, imaging
protocol, comparison group and preprocessing protocol [105].
3.3 Results
We found 106 candidate articles from searching the mentioned databases.
Any review articles among the 106 articles were read and any papers they cited relating to
MS, resting-state and fMRI were manually included into the title and abstract screening. We
found 23 additional papers cited in the reviews, resulting in a total of 129 candidate articles. Of
these, 60 were excluded at the title and abstract screening stage. Reasons for exclusion were
studies of patients without MS, no resting-state, no fMRI (e.g. Diffusion Tensor Imaging (DTI)
only) and not original research studies (i.e. reviews). At the full text screening stage, 41 studies
were excluded. Reasons for exclusion were repeated papers, studies not in English, no diagnostic
criteria given, abstract only for poster/oral presentation, and no pure resting-state (i.e. time
slices from different periods of rest in-between tasks, concatenated together). In total, of the 129
articles 28 met the inclusion criteria. See Figure 3.2 for a breakdown of the article numbers in
each stage of the review.
3.3.1 Quality assessment
The number of studies found investigating pure resting-state fMRI is low, however (in terms of
how much a study fulfilled our criteria) the quality of these studies is high. Only four studies did
not fulfil all the criteria; see Table 3.9 for quality assessment results.
When MS participants were compared to HC participants the two groups were well matched
in nearly all the studies, the majority matching for age, sex and education level. This is good
study design as these variables have been shown to affect FC [32], and not matching them could



















Figure 3.2: Diagram of review steps.
3.3.2 MS phenotypes and diagnostic criteria
All the articles used either the McDonald criteria [89], 2005 revisions to the McDonald critera
[116] or 2010 revisions to the McDonald criteria [115].
The phenotype of MS in participants was Relapsing Remitting MS (RRMS) in 19 studies; of
which two [146, 157] used the original McDonald criteria, nine [12, 13, 50, 68, 75, 76, 114, 122,
171] used the 2005 revision to the McDonald criteria and eight [28, 29, 31, 41–43, 170, 172] the
2010 revision. A combination of RRMS and Clinically Isolated Syndrome (CIS) was used in two
studies; one [124] using the 2005 revision and one [51] the 2010 revision. Another study used
a combination of RRMS and CIS but also included unspecified MS type participants [60]. This
study used the original McDonald criteria. A combination of RRMS and Secondary Progressive
MS (SPMS) was included in three studies; two [35, 133] using the 2005 revision and one [65]
the 2010 revision. Finally, three studies used a combination of RRMS, Primary Progressive MS
(PPMS) and SPMS; two [131, 135] using the 2005 revision and one [132] using the 2010 revision
of the McDonald criteria.
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3.3.3 Study aims and size
Main study aims varied: for four studies [75, 76, 170, 172] the aim was to determine differences
between MS and HC; another study [171] also compared MS and HC though their main aim
was exploring how FC measurements were correlated with clinical neurological scales. For two
studies the main aim [12, 28] was comparing cognitively preserved with cognitively impaired MS
patients. Two studies [13, 31] examined the impact of a computer rehabilitation program. One
study [29] focused on the impact of fatigue. Six studies [35, 41, 42, 68, 131, 132] investigated the
impact of disability on FC. Four studies [60, 65, 146, 157] focused on cognition, one of which [65]
focused on memory performance, and two [146, 157] examined both cognition and disability. Four
studies [43, 51, 114, 124] explored changes in FC evidenced in early MS (i.e. CIS or early RRMS).
One study [50] explored changes in FC due to optic neurosis. One study [133] focused on how
gender affects FC and cognition. One study [135] looked at how pain affected FC, and one unique
study [122] described a classifier they developed, based on a random forest scheme, to classify
participants’ fMRI data into either MS or HC.
The maximum number of MS participants in a study was 157, with the minimum number
being 13. For studies that included HC participants the maximum and minimum number of HCs
were 50 and 11 respectively. Overall, the number of MS participants in the studies were 40±32
(mean ± std) and for HC was 24±11 (mean ± std) (for studies that included HCs). See Table 3.8
for full study demographic details.
3.3.4 Data acquisition and analysis methods
Two-thirds of the studies [12, 13, 28, 29, 31, 50, 68, 75, 76, 114, 122, 131, 132, 135, 146, 157, 170–
172] had scan length times of 9 minutes or less (9±4 minutes, mean ± std); 85% [12, 13, 28, 29,
31, 41–43, 50, 65, 68, 75, 76, 114, 124, 131–133, 135, 146, 157, 170–172] had 300 volumes or less
(241±109 volumes, mean ± std); 85% [28, 29, 31, 35, 41–43, 51, 60, 65, 68, 75, 76, 114, 124, 131–
133, 135, 146, 157, 170–172] had a time to repetition (TR) of greater than or equal to 2 seconds
(2344±653 milliseconds, mean ± std).
Various methods were used to explore neuroplasticity in MS, which we split into six cate-
gories: independent component analysis (ICA), seed to voxel, region of interest (ROI), automated
anatomical labelling (AAL) network measures, amplitude of low frequency fluctuations (ALFF)
and voxel to voxel. Below we describe how each method defines locations within the brain and
how they calculate FC.
ICA measures coherent fluctuations between groups of voxels and was used in 13 studies:
10 exclusively [12, 13, 28, 41, 43, 50, 68, 114, 124, 135], one [29] in combination with a seed
based analysis, one [35] in combination with a ROI based analysis and one [170] used ICA to
78
3.3. RESULTS
define their own ROI locations. A Seed to voxel technique correlates every voxel in the brains
BOLD signal separately with a chosen seed locations (usually averaged) BOLD signal. Groups of
voxels with significant correlation values are then tested with multiple comparison and cluster
size statistical tests. Voxel clusters passing these tests are then reported to be affected. Six
studies were identified as using a seed to voxel analysis: five exclusively [31, 75, 131, 146, 157]
and one in combination with ICA [29]. The study which used it in combination with ICA used
Pearson’s correlation coefficient to measure FC whilst all the other studies did not specify how
they calculated it. A ROI analysis method looks at multiple regions of averaged BOLD signal
voxels and compares them to each other, rather than comparing at a voxel level. Four studies
used a ROI analysis in their papers. Two used the AAL atlas to define ROIs, focusing on thalami
ROIs in one study [133] or adding custom hippocampal ROIs to focus on in another [65]. Both
these studies measured FC using synchronization likelihood (SL). Another study [170] used ICA
to define ROI locations, measuring FC between them using Pearson’s correlation coefficient. One
study [35] used ICA on a ROI defined by a previous activation study.
The AAL atlas is a brain segmentation based on anatomy. Six studies were identified as
using an AAL atlas analysis; two [65, 133] to define ROIs in a ROI analysis, three [42, 51, 132]
to measure network properties and one [122] using the AAL atlas to build a classifier. Of the
studies that measured network properties one [42] did not specify how they measured FC, one
[51] used Pearson’s correlation coefficient and the other [132] used SL. The study which built
a classifier [122] used Pearson’s correlation coefficient to measure FC. Two studies [76, 171]
used Amplitude of low Frequency Fluctuations (ALFF) which measures intrinsic oscillation
amplitude. Two studies performed a voxel to voxel analysis (Table 6), one [60] between 40,000
voxels spanning the cortex using Pearson’s correlation coefficient, and the other [172] measuring
Pearson’s correlation coefficient between all the voxels in a sensorimotor network mask.
3.3.5 Neuroplasticity in MS
The studies found in this review demonstrated possible neuroplasticity in MS either in terms of
anatomy (i.e. a physical part of the brain), in terms of a resting-state functional network (which
can involve many distinct regions of the brain) or as a network measure.
ICA
Thirteen studies used ICA [12, 13, 28, 29, 35, 41, 43, 50, 68, 114, 124, 135, 170]. See Table 3.2 for
results.
The default mode network (DMN) was found to be effected in seven of these [12, 13, 28, 43,
124, 135, 170]. Two studies showed increased DMN FC in MS compared to HC [41, 65], one study
[12] found both increased and decreased FC in specific regions within the DMN, one [28] study
showed a decrease in FC in the DMN in cognitively impaired patients only compared to HCs,
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one study [124] indicated an increase in FC in DMN in CIS compared to RRMS, one study [135]
showed increased FC in no-pain patients versus patients who experienced pain and one study [13]
observed an increase in DMN FC after a computer-based cognitive rehabilitation program. Motor
networks were found to be affected in four studies [35, 41, 68, 124]. One study [35] only showed
a correlation between EDSS score and FC between motor resting-state network and dorsal
pre-motor cortex (PMd). One study [41] observed an increase in motor network FC which also
correlated with the activation level of an area activated during a separate task. Another study
[124] demonstrated an increase in CIS participants only and one study [68] found a decrease
in FC in MS compared to HCs, which was also negatively correlated with disease severity. The
frontoparietal network (FPN) was shown to be affected in four studies [28, 43, 114, 124]. One
study [28] found decreased FC in the FPN in MS compared to HCs, another study [43] indicated
increased FC, one study [114] showed an increase in FC in the FPN in MS participants who had
undertaken a repetitive thumb flexions (RTF) exercise and another study [124] demonstrated an
increase in FC in CIS patients compared to RRMS. Visual resting-state networks were affected in
four studies [43, 50, 68, 114]. Two studies [43, 114] showed an increase in FC in visual networks
in MS compared to HC and two studies [50, 68] found a decrease. One study [50] demonstrated
increased FC between the visual resting-state network and extrastriate cortex in patients with
previous optic neuritis and another study [68] showed disease severity to be positively correlated
with medial visual network FC. The sensorimotor network (SMN) was affected in three studies
[29, 43, 124]. All three studies found increased FC in this network in MS compared to HCs,
though one of them [29] observed an increase in non-fatigued patients only and another study
[124] indicated an increase in CIS patients only.
The executive function network was affected in two studies [114, 124]. One [114] found
increased FC in this network after RTF exercises. Another study [124] showed FC in this network
increased in MS compared to HC in CIS patients only. Auditory networks were found to be
affected in one study [114] which demonstrated increased FC in MS compared to HC, and also
showed FC to be increased post RTF compared to before RTF. The prefrontal insular resting-state
network was observed to be increased in MS compared to HC in one study [43] which also
found MS functional composite measure (MSFC) scores to negatively correlate with the FC of
this network. The attention network had increased FC in MS compared to HC in one study
[124], although this was for CIS only. CIS patients also expressed increased FC in this network
compared to RRMS patients. The attention network was affected in two studies [114, 124]. One
[124] found increased FC in MS compared to HC, though this was for CIS only. The same study
also observed increased FC in this network in CIS compared to RRMS patients. The other study
[114] demonstrated that this network only had increased FC in post RTF compared to before
RTF. The cerebellar network (CBN) had increased FC in RRMS compared to HC in one study
[114] which also showed an increase in FC in this network in post RTF compared to before RTF.
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The control network was found to be affected in one study [68] which demonstrated a negative
correlation between FC in this network and disease severity.
Seed to voxel
Six studies used a seed to voxel analysis [29, 31, 75, 131, 146, 157]; see Table 3.3 for results.
The thalamus displayed significantly altered FC with different voxel clusters of the brain in
MS compared to HC in four studies [31, 75, 131, 146]. One study [31] found only clusters with
decreased FC located in the cerebellum, frontal and occipital cortices and the caudate nucleus.
Another study [131] observed only increased clusters located in the sensorimotor cortex and
ventral stream. Two studies [75, 146] showed clusters with both increased and decreased FC to
the thalamus. Clusters with increased FC were located in the thalamus for one of the two studies
[75] and in the cerebellum, basal ganglia, hippocampus, cingulum, bilateral temporal-occipital
cortices, bilateral insular cortices, bilateral dorsal-frontal cortices and parietal cortex in the other
study [146]. Clusters with decreased FC were found in the right middle frontal gyrus, right
parahippocampal gyrus and left inferior parietal lobule for one study [75] and in the thalamus,
cerebellum, cingulum, bilateral prefrontal cortices and bilateral parietal-occipital cortices in the
other study [146]. A study [31] that compared participants who undertook a rehabilitation pro-
gram (intervention group) to those who did not (control group) found clusters with both increased
and decreased FC to the thalamus in the intervention group compared to the wait group. Disease
duration was found to be negatively correlated with between-thalami FC in another study [75].
Expanded disability status scale (EDSS) score was negatively correlated with thalami eigenvector
centrality mapping (ECM) values in one study [131]. In the other study [146] PASAT scores were
negatively correlated with thalami FC.
The primary motor cortex (PMC) had significantly decreased FC with the left primary so-
matosensory cortex in MS compared to HC in one study [29]. Fatigue severity status scores
were also negatively correlated with the FC between the PMC and supplementary motor area
(SMA). One study [131] found clusters with both increased and decreased FC with a sensorimotor
seed, increased clusters were located in the thalamus and decreased clusters in the ventral
stream. The same study [131] showed both increased and decreased FC also with a ventral
stream seed. Increased FC was observed in the thalamus and decreased FC in the sensorimotor
cortex. The ECM values of a central stream seed were correlated with cognition in one study
[146]. A posterior cingulate cortex (PCC) seed in MS compared to HC had decreased FC with
other voxel clusters located in the anterior cingulate cortex (ACC) and right inferior frontal
gyrus [157]. FC between a ventral medial pre frontal cortex (vmPFC) seed and a left frontal pole
region was correlated with more stable performance on a semantic search reaction time test [157].
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ROI analysis
Four studies used a region of interest (ROI) based analysis [35, 65, 132, 170]; see Table 3.4 for
results. Expanded disability status scale was correlated with the connectivity between a dorsal
premotor cortex (PMd) ROI and bilateral motor resting-state network signals in a study [35].
This correlation was only significant in RRMS, not SPMS. In another study [65], hippocampal
ROIs (one left and one right) were correlated with AAL atlas time series ROIs, and they found
increased FC in both hippocampi with the AAL in MS compared to HC. Memory performance
was also correlated with increased FC of the left hippocampus. In another study [132], thalami
ROIs were correlated with the AAL atlas time series where they found increased FC in MS with
the thalami compared to inferior frontal gyrus, middle cingulate gyrus and inferior temporal lobe.
Thalamic weighted degree was also increased in cognitively impaired versus cognitively preserved
MS participants. Another study [170] used ICA to define DMN ROIs. These were based in the
medial prefrontal cortex (MPFC), the left and the right inferior parietal lobules (IPL), the left
and the right medial temporal lobes (mTL) and the posterior cingulate/precuneus (PCC/PCUN).
All these ROIs showed increased FC, and none of them showed decreased FC. Paced auditory
serial addition test (PASAT) scores were negatively correlated with the FC between the right
mTL and PCC/PCUN.
AAL Atlas network measures
Two studies [65, 132] used the AAL as ROIs, which have been interpreted as ROI analysis rather
than AAL analysis; see ROI analysis (Section 3.3.5). Of the studies that focused on the AAL all
but one used the atlas to calculate different network measures. The one study that did not instead
used it as part of a tool to classify fMRI data into either MS or HC [122]. Network measures found
to be increased in MS compared to HC were nodal efficiency [42], local efficiency [42], connectivity
index [42] and modularity [51]. Network efficiency and connectivity of 26 regions (in male MS vs
male HC only) was found to be decreased in one study [133]. See Table 3.5 for results.
ALFF
ALFF was used in two studies [76, 171]. The bilateral thalami showed increased ALFF in both
these studies with one of the studies [171] observing a correlation between PASAT and thalami
ALFF and between mean fractional anisotropy and left thalami ALFF. Two other regions found
to have increased ALFF in MS compared to HC were the right insula and the right superior





Voxel to voxel analysis was used in two studies. The first study [60] found increased FC in the
DMN and control network. This study also found that cognitively efficient MS participants had
greater FC in the control network and reduced FC in the DMN. The other study [172] found
regions with both increased and decreased degree centrality and eigenvector centrality. See Table
3.7 for results.
3.3.6 Early MS
In three studies, neuroplasticity was found to be more prominent early on in disease progression.
Roosendall et al. 2010 [124] found an increase of FC only in CIS which disappeared with disease
progression. Liu et al. 2015 [75] found a negative correlation between disease duration and
inter-thalamic FC. Gomboa et al. 2014 [51] and Faivre et al. 2012 [43] looked solely at early MS.
All three studies suggest that functional reorganisation of the brain occurs predominately at an
early stage of the disease. The reorganisation is a possible initial attempt by the brain to limit its
functional atrophy.
3.3.7 Comparing MS to HC
Three studies did not have a comparison group, i.e. healthy controls; instead they compared MS
patients before and after a cognitive task [13] or compared MS’ FC with their clinical disability
[35] or compared participants with chronic pain to those without [135]. Other studies whose main
interest was not in comparing MS to HC still included HCs for extra comparison. For example,
exploring how FC is altered by fatigue [29], how FC is altered by a cognitive rehabilitation
program [31], how FC is altered by previous optic neuritis [50] or how FC in MS differs between
genders [133]. The remaining studies all found differences between MS and HC, though their
main aims were usually to explore how a clinical marker(s) of their choice is reflected through
changes in FC.
3.3.8 Correlations with clinical markers
Conclusions about adaptive mechanisms in the brain were usually drawn by correlating a FC
measure with a clinical marker. For example, Liu et al. 2015 [75] found a negative correlation
between disease duration and between-thalami seed connectivity. They also found the between-
thalami FC significantly greater in MS than HC. The authors concluded that their results suggests
an adaptive role of the thalamus that is gradually lost as the disease progresses. Another example
is the study by Dogonowski et al. 2013 [35] who demonstrate a positive correlation between EDSS
score and FC between the motor resting-state network and the dorsal pre-motor cortex (PMd).
This correlation was only present in RRMS, not SPMS, evidencing beneficial cortical adaptation
with the integration of the PMd into the motor resting-state network.
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3.4 Discussion
The most robust differences in FC between MS and HC groups were observed in the DMN, motor,
visual and FPN networks as well as the thalamus. The DMN is one of the major networks associ-
ated with resting brain activity and is thought to represent internal cognition. The activation
of the DMN is negatively associated with cognitive performance [135]. However, the findings
from the studies included in the current review are inconsistent. Some studies show increased
FC [41, 65], some show decreased FC [12] and some show both increases and decreases in FC
[28] in the DMN for the MS groups compared to controls. Decreased FC may suggest disruption
to the DMN, which is associated with cognitive impairment [12, 13, 28]. Increased FC, on the
other hand, may suggest a form of compensation facilitated by neuroplasticity. However, the
inconsistent findings across the literature make interpretations difficult. This inconsistency
may be due to the heterogeneity in MS. MS is heterogeneous in terms of aetiology, pathology,
symptomology and cognition. Further research using larger sample sizes are required to increase
the reliability and validity of results. However, it may be possible that due to the heterogeneity
there may be subtle differences in the neuroplasticity between MS populations, and that this
process occurs on an individual level. I.e. the differences could cancel out when looking at a group
level.
The findings of altered FC in visual and motor networks in MS is in line with the visual
and motor disturbances associated with MS. This is further evidenced by the FC in these net-
works being correlated with disability. However, even in these networks the finding of FC is
inconsistent, with some studies showing increases [41, 43, 114] and other studies decreases in
FC [50, 68]. This inconsistency provides further evidence for the heterogeneity in MS, and it has
some implications for the implementation of FC analysis. As even in well-defined networks, the
results are inconsistent. This pattern of inconsistency has also been observed in the FPN network.
This network is proposed as a key network for memory and cognition, where the parietal lobe
integrates sensory information and then relays this to higher cognitive regions in the frontal lobe
and is therefore particularly vulnerable to cognitive impairments [28]. Together the results do
show neuroplasticity in MS. However the exact nature of the plasticity is inconsistent across the
different studies and may adapt to the individuals’ brain, thereby leading to inconsistent results
in the literature.
The thalamus has multiple projections throughout the brain, through which it acts as a
relay centre for a multitude of functions including motor [88, 137, 162], sensory [137, 162], and
higher order cognitive functions such as memory [151] and attention [96, 113, 142, 143]. Fur-
thermore, the thalamus is involved in other functions such as regulation of arousal in sleep
and wakefulness [27, 129], where damage to the thalamus may result in a coma [10]. Given its
widespread function, the thalamus’ connectivity is important. However, the findings of FC in the
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thalamus of the MS brains are inconsistent between studies. Some studies showed increased
FC [75, 131, 146], whereas other studies showed decreased FC [31, 75, 146]. The inconsistency
may be due to the large amount of heterogeneity in MS, where some participants are able to
compensate for neuronal damage via neuroplasticity, whereas other participants are not. It may
even be that the neuroplasticity adapts to the individuals’ brain, leading to inconsistency across
studies. Furthermore, due to its multiple connections it is difficult to determine whether the
thalamus is directly involved in the pathological process, or whether it is susceptible to pathology
from regions to which it is connected [92].
Even the most robust finding of FC changes in the DMN was only demonstrated in seven of
the twenty-eight studies. This may be due to the fact that very few studies examine whole-brain
connectivity, but rather choose specific regions on which to focus, based on previous studies. Each
method has its advantages and disadvantages. Although a region-specific analysis may lead to
more power despite smaller sample sizes, it may also miss key changes in the brain. Specifically
in a group as heterogeneous as MS, where there is little consensus in the research, choosing
regions based on previous studies seems ineffective. Whole-brain analyses can overcome this,
however they often require much larger samples and therefore greater resources. The recent
development of whole-brain topology measures [18] overcomes this limitation to some extent, by
characterising local and global measures of a chosen network. However this again requires ROIs
to be determined prior to the analysis.
Similarly, each analysis method has advantages and disadvantages and often the analysis
technique employed relies upon the aim and hypotheses of a particular study. ICA is predomi-
nantly used as an exploratory tool, where there is no hypothesis to test. An advantage of ICA
is that it is multivariate, needing no choice of region to explore; as a choice of region could be
arbitrary or open to bias. ICA also requires no temporal model (i.e. the General Linear Model).
Disadvantages are that it requires previous knowledge about functional brain networks to in-
terpret the results. In fMRI, ICA is essentially on a voxel level, therefore care also has to be
taken when looking for statistically different connectivity patterns between groups, for example
multiple comparison and cluster size testing.
Seed and ROI based analysis have the advantage that their results are easier to interpret,
because the selected seed/ROIs can be directly shown to be affected by MS. It also has a much
lower dimensionality because the focus is on only a few seeds or at most a few hundred ROIs.
This type of analysis is also spatially specific and able to provide information about how the
connectivity between different regions of the brain compares between populations. However, it
requires previous knowledge/expertise to select what regions to analyse, which is often difficult
in a heterogeneous population as in MS. This is especially so for seed based analysis, which in
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general focus on a lower (often singular) number of regions.
Network analysis using the AAL atlas has similar advantages and disadvantages to ROI
based analysis, because the AAL atlas is essentially a segmentation of the brain into ROIs based
on anatomy. The studies found in the review used the AAL almost exclusively for calculating
network measures. These measures generally do not give spatial information but do highlight
effects to the functional network topology of the brain. This is not a disadvantage to the AAL
atlas itself, but to the type of analysis we found to be commonly deployed with it.
ALFF has the advantage of being a relatively simple metric to calculate and it gives signal
information about a specific region. However, it does not elucidate the functional connectivity
between different regions.
Finally, voxel to voxel correlation has the advantage of being multivariate, able to give infor-
mation about connectivity between many regions and not requiring a priori information. However,
it is computationally expensive with a large number of correlation values to calculate, and again
care has to be taken when looking for statistically different connectivity patterns between groups.
Scan length has been shown to be an important variable for reliability of rs-fMRI results,
with scan lengths of 9-13 minutes or longer greatly improving the technique [11]. The majority of
studies found in this review do not meet this threshold. Therefore future studies should increase
the total scanning time and volume number of their resting-state scans to increase the reliability
of results. Furthermore, some studies claim to conduct rs-fMRI, however they only concatenate
periods of rest between task-based fMRI [77].
Over 90% of individuals with MS experience fatigue [16]. Despite its subjective nature, it
has a widespread impact on employment [48, 69], quality of life [67] and has significant cost
implications [70]. However, only one study identified in this review focused on fatigue as their
main aim, with the majority of studies focusing more on disability or cognitive function. Despite
the widespread impact of fatigue there is a significant lack of research in this area. More research
into the neural substrates of MS fatigue is required to improve our understanding and assessment
of potential treatments to have real world benefit.
Most of the studies were cross-sectional and therefore do not take into account that MS
participants have a degenerative disease and that their brains activity cannot be assumed to
stay the same. More longitudinal studies could give helpful information as to how, and the rate at
which, a MS patients’ brain reorganises in response to the disease. Studies specifically following
participants from onset of the disease could shed light on the effect of disease progression of MS
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and expand the early MS results brought up in this review.
Due to the low number of studies, and large variety of focus of the studies, conclusions
about their results are limited due to the lack of reproducibility. A benefit would be for future
studies to try and replicate some previous findings, following the same methods but with a
larger sample size of participants. This would give more validity and reliability to the results. A
further, more practical, recommendation for future studies would be to include more detail of
their preprocessing, stating more specifically what the steps were, rather than saying they just
followed a standard protocol. The preprocessing protocol can have a major effect on the results of
a study [136], affecting reliability and group discriminability. Inclusion of a detailed protocol, or
even a template batch script, would greatly help in assessing the results from a given study.
3.5 Conclusion
Pure resting-state fMRI studies, observing neuroplasticity in MS were low in number and high
in quality. The type of study, and methods used for analysis varied making a comparison of
results difficult. This review identified six different methods used to assess neuroplasticity in
the MS brains, each of which has specific advantages and disadvantages and were chosen based
on the aims and hypotheses of the study. These various techniques display a range of different
forms of evidence demonstrating alterations to the brain’s functional organisation. The results
showed evidence of neuroplasticity predominantly in the default mode network (DMN), motor
network, visual network, frontal parietal network (FPN) and the thalamus. Although there
are inconsistencies in whether this results in increased or decreased FC. The inconsistencies
may be due to the heterogeneity in MS. It is recommended that studies with larger sample
size are conducted to overcome the problem of heterogeneity and increase the reliability and
reproducibility of the results.
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Table 3.2: Summary of studies which used ICA to find evidence of
neuroplasticity in MS versus HC.
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[170] DMN (ICA used to
define ROIs)







FC: Functional connectivity, DMN: Default mode network, CBN: cerebellar network, CP: Cognitively preserved, CI: Cognitively impaired, cCR:
Computer-based cognitive rehabilitation, aCT: Aspecific cognitive rehabilitation, PCC: Posterior cingulate cortex, IPC: Inferior cingulate cortex, SMN:
Sensorimotor cortex, F: Fatigued, NF: Not Fatigued, FPN: Fronto parietal network, EDSS: Expanded disability status scale, PMd: Dorsal pre-motor
cortex, RRMS: Relasping Remitting MS, SPMS: Secondary Progressive MS, VLPC: Ventrolateral prefrontal cortex, PASAT: Paced auditory serial
addition test, MSFC: Multiple sclerosis functional composite measure, RSN: Resting-state network, RTF: Repetitive thumb flexions, CIS: Clinically
isolated syndrome
Table 3.3: Summary of studies which used a seed to voxel analysis to find
evidence of neuroplasticity in MS versus HC.
Name Seed(s) with in-
creased FC clus-
ters in MS vs HC
Seed(s) with de-
creased FC clus-
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PMC: Primary motor cortex, FSS: Fatigue severity scale, SMA: Supplementary motor area, EDSS: Expanded disability status scale, PMd: Dorsal
pre-motor cortex, PASAT: Paced auditory serial addition test, ACC: Anterior cingulate cortex, PCC: Posterior cingulate cortex, SSRT: Semantic search
reaction time, vmPFC: Ventral medial prefrontal cortex
Table 3.4: Summary of studies which used a ROI analysis to find evidence of
neuroplasticity in MS versus HC.
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MPFC: Medial pre-frontal cortex, IPL: Inferior parietal lobules, mTL: Medial temporal lobe, PCC/PCUN: Posterior cingulate cortex/precuneus, PASAT:
Paced auditory serial addition test, CI: Cognitively impaired, CP: Cognitively preserved
Table 3.5: Summary of studies which performed a network analysis with AAL
ROIs to find evidence of neuroplasticity in MS versus HC.
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[133] None found Network efficiency,
connectivity of 26
regions (male MS
vs. male HC only)
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[132] Used AAL as ROIs with additional thalamus ROIs. See ROI table (Table 3.4).
[65] Used AAL as ROIs with additional hippocampal ROIs. See ROI table (Table 3.4).
EDSS: Expanded disability status scale, MSFC: Multiple sclerosis functional composite, T2-LL: T2-Lesion load, CI: Cognitively impaired, CP: Cogni-
tively preserved
Table 3.6: Summary of studies which used a ALFF analysis to find evidence of
neuroplasticity in MS versus HC.
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EDSS: Expanded disability status scale, ALFF: Amplitude of Low Frequency Fluctuations, PASAT: Paced auditory serial addition test
Table 3.7: Summary of studies which used a voxel to voxel analysis to find
evidence of neuroplasticity in MS versus HC.
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DMN: Default mode network, EDSS: Expanded disability status scale, M1: Primary motor cortex, S1: Primary somatosensory cortex, TWMLL: To-
tal white matter lesion load, BPF: Brain parenchymal fraction, DC: Degree centrality, EC: Eigenvector centrality, OP: Operculum parietal, SMA:
Supplementary motor area, IPL: Inferior parietal lobule
Table 3.8: Summary of participant demographics in the studies.





[12] 36 RRMS 18 Matched for sex, age and educa-
tion
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[29] 60 RRMS 18 RRMS classified as fatigued
(n=32) and not fatigued (n=28)
[28] 60 RRMS 18 RRMS classified as cognitively
impaired (n=30) and cognitively
preserved (n=30). HC all right
handed
[31] 24 RRMS 11
[35] 27 RRMS 0
[41] 13 early RRMS 14 Matched for sex and age
[43] 13 early RRMS 14 Matched for sex, age and educa-
tion
[42] 38 RRMS 24
[50] 30 RRMS 15 RRMS classified as with optic neu-
ritis (n=14) and without optic neu-
ritis (n=16)
[51] 8 RRMS, 8 CIS 20 7 RRMS and 8 CIS for session 3
[60] 12 RRMS, 2 CIS, 2 MS 16 Matched for sex, age and educa-
tion
[65] 40 RRMS, 17 SPMS 28 Matched for sex, age and educa-
tion
[68] 28 RRMS 28 Matched for sex, age and educa-
tion
[75] 35 RRMS 35 Matched for sex and age
[76] 35 RRMS 35 Matched for sex and age
[114] 20 RRMS 14 Matched for sex and age. RRMS
all right handed
[122] 22 RRMS 14
[124] 31 RRMS, 14 CIS 41 Matched for sex and age
[131] 112 RRMS, 7 PPMS, 9 SPMS 50 Matched for sex, age and educa-
tion





[133] 30 CDMS 30 Matched for age, education and
pre morbid IQ. Male and Female
MS (12 male RRMS, 3 male SPMS,
14 female RRMS, 1 female SPMS)
matched for disease duration, dis-
ability and lesion load
[135] 14 RRMS, 8 SPMS, 1 PPMS 0 12 MS with chronic pain (7 RRMS,
4 SPMS, 1 PPMS) and 11 with-
out (7 RRMS, 4 SPMS, 0 PPMS)
matched for sex, age, disease du-
ration and EDSS
[146] 55 RRMS 24
[157] 18 RRMS 16 All female, matched for age and
education
[170] 24 RRMS 24 Matched for sex, age and educa-
tion
[171] 23 RRMS 23 Matched for sex and age
[172] 34 RRMS 34 Matched for sex, age and educa-
tion
RRMS: Relapsing-remitting MS, PPMS: Primary-progressive MS, SPMS: Secondary-progressive MS, CDMS: Clinically definite MS, CIS: Clinically
isolated syndrome, EDSS: Expanded disability status scale
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[12] Y Y Y Y Y Y N
[13] Y Y Y Y Y N N
[29] Y Y Y Y Y Y Y
[28] Y Y Y Y Y Y Y
[31] Y Y Y Y Y Y Y
[35] Y Y Y Y Y N Y
[41] Y Y Y Y Y Y Y
[43] Y Y Y Y Y Y Y
[42] Y Y Y Y Y Y Y
[50] Y Y Y Y Y Y Y(W)
[51] Y Y Y Y Y Y Y
[60] Y(W) Y Y Y Y Y Y
[65] Y Y Y Y Y Y Y
[68] Y Y Y Y Y Y Y
[75] Y Y Y(W) Y Y Y Y
[76] Y Y Y(W) Y Y Y Y
[114] Y Y Y Y Y Y Y
[122] Y Y Y Y Y Y Y
[124] Y Y Y(W) Y Y Y Y
[131] Y Y Y Y Y Y Y
[132] Y Y Y(W) Y Y Y Y
[133] Y Y Y Y Y Y Y(W)
[135] Y Y Y Y Y(W) N Y
[146] Y Y Y Y Y Y Y
[157] Y Y Y Y Y Y Y
[170] Y Y Y Y Y Y Y
[171] Y Y Y Y Y Y Y
[172] Y Y Y Y Y Y Y









ANALYSING LARGE SCALE FUNCTIONAL NETWORKS IN MULTIPLE
SCLEROSIS
The brain is widely regarded as one of the most complex objects known, with many inter-acting components. Due to this complexity, our understanding of how the brain worksand how it can be affected is limited. As the brain is composed of many interconnected
parts, viewing the brain as a network is a natural way in which it can be analysed to further our
understanding [46].
Many disorders affect the brain, one of particular interest is Multiple Sclerosis (MS), a de-
myelinating disease of the central nervous system. MS is a leading cause of disability in young
adults and its prevalence around the world is increasing [17]. Using functional magnetic reso-
nance imaging (fMRI), an indirect measure of activity within the brain, we can create functional
networks and see if properties of these networks differ between MS and Healthy control (HC)
participants. This could elucidate how the disease progresses and inform on the effectiveness of
treatments.
fMRI is a method which uses MRI to indirectly measure activity within the brain. Oxygenated
blood behaves differently under a magnetic field than de-oxygenated blood, and an MRI scanner
can use this to measure blood flow around the brain, recording a blood oxygen level dependent
(BOLD) signal. As brain cells require oxygen to function, and when more active require more
oxygen, the BOLD signal is an indirect measure of activity within the brain.
Traditionally, fMRI has been used to see which areas of the brain are more active during
a task. More recently there has been a growing interest in resting-state fMRI [119], a way of
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measuring the intrinsic connectivity between parts of the brain, termed functional connectivity
(FC), in its basal state. Alterations in FC between MS and HC participants could be evidence
of neuroplasticity in the MS brains, functioning as a compensatory mechanism. The review of
Chapter 3 describes studies we found which looked at evidence of neuroplasticity in MS from
resting-state fMRI studies. The main conclusions from this review are that MS is highly hetero-
geneous, reflected in the conflicting results reported, and that there is a lack of research into one
of the main effects from the disease, fatigue.
There is a prevalence of fatigue in MS [16], and this is the main reason the study of this
chapter was carried out. The analysis we performed can be broadly split into two parts; hypothesis
driven and exploratory. The hypothesis is there is disruption to the basal ganglia caused by MS;
the basal ganglia is a subcortical structure of the brain whose disruption has been assiciated
with fatigue [22]. One of the symptoms of this disruption may be the fatigue experienced by
the MS participants. The exploratory analysis we carried out was looking at different global
network measures of the FC between regions of the brain. We looked at a number of different
measures with no prior expectation of exactly how they might differ between the two populations.
Disruption to a network measure could be evidence of compensatory neuroplasticity, which
could indirectly explain the MS participants fatigue, as a different FC structure may use more
metabolic energy.
4.1 Background of study
Participants were recruited by CRICBristol, who recruited 40 HC and 38 MS participants. They
all performed a number of tests whilst inside the scanner, i.e. task-based fMRI, but also spent
a period of the scanning at rest, i.e. resting-state fMRI. The analysis in this chapter is looking
solely at the resting-state fMRI. Resting-state designs require no engagement from participants,
require no experimental design and are an increasingly popular way of investigating basal brain
activity. The resting-state scan we used had a time to repetition (TR) of 906ms (i.e. a sampling
frequency of 10.906 ) and recorded 300 volumes, with a total resting-state scanning time of 4.53
minutes. This is shorter than the recommended 9-13 minutes or longer as highlighted in the
review of Chapter 3. The main reason for this was the study paradigm performed by CRICBristol
involved tasks and a period of resting-state, and time constraints in the scanner resulted in a
compromise between the two.
The reason CRICBristol performed this study was because of the aforementioned prevalence
of fatigue in MS, and differences found between HC and MS could explain what may be causing
this fatigue. We used a network analysis, abstracting regions of the brain as nodes of a network,
and the correlation between the regions activity as the edges of the network. We measured
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different properties of these networks and compared them between the two populations to test
for a difference in the functional workings of the MS populations brains.
4.2 Study participants
CRICBristol initially recruited 40 female participants (aged 32-67, mean 49.8) with a clinical
diagnosis of MS, from The Brain Centre at Southmead Hospital, North Bristol Foundation Trust,
UK. Diagnosis were made according to the McDonald criteria [89, 115, 116]. The 40 female HC
participants (aged 31-68, mean 49.5) were matched for age (and gender). A technical problem on
the computer system used to store the study data resulted in two of the MS participants data
being corrupted; resulting in the final 38 MS participants (aged 32-67, mean 49.9).
Of the 38 MS participants, 25 were diagnosed with relapsing-remitting MS (RRMS), 4 with
primary progressive MS (PPMS) and 9 with secondary progressive MS (SPMS) See Table 4.1 for
MS participant demographics (diagnosis, age and disease duration).
Diagnosis Number of partici-
pants




25 46.8 (32-67) 8.96 (1-29)
Primary progressive
MS (PPMS)
4 57 (52-59) 9.25 (6-14)
Secondary progressive
MS (SPMS)
9 55.2 (40-65) 23.6 (12-36)
Table 4.1: Table detailing breakdown of MS particpants by diagnosis, age and
disease duration. Mean (Range).
4.3 Preprocessing
Before any comparison between groups can be made, the images acquired need to be cleaned up
and prepared for analysis in a process called preprocessing. This is because fMRI is inherently
noisy and participants do not keep perfectly still during the scanning, among other reasons
discussed in Sections 4.3.1 and 4.3.2. Preprocessing was performed in SPM12 [112] (see below)
within MATLAB and further preprocessing was performed using custom code in MATLAB.
4.3.1 SPM preprocessing
Statistical parametric mapping (SPM) is a MATLAB toolbox developed by members and collabo-
rators of the Wellcome Centre for Human Neuroimaging. SPM12 was the version we used for
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preprocessing and analysis of the fMRI data, though it is also capable of analysing data from
PET, SPECT, EEG and MEG as well. We only used the preprocessing parts of SPM12, performing
further preprocessing and analysis separately in MATLAB. During the scanning a structural
image is acquired in addition to the BOLD functional scans, this is used by SPM as part of the
preprocessing.
The first step is realignment, which uses a least squares approach to a rigid body 6-parameter
spatial transformation to calculate the head movement of the participant. Figure 4.1 shows
the calculated movement parameters of a HC participant, Figure 4.1a showing the x, y and z
translation motions, and Figure 4.1b showing the pitch, roll and yaw rotation motions. Scans are
then adjusted, using these calculated movement parameters, to realign them with the first image
in the series.
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Figure 4.1: Calculated movement parameters of a single HC participant. a
Translation movement. b Rotation movement.
The next step is corregistration. This procedure uses the structural scan as a reference
image fixing it in place, whilst jiggling the mean of the functional scans such that the mutual
information between the two is maximized. The rest of the functional scans are altered the same
as their mean, bringing all the functional images in alignment with the structural image. After
this, segmentation is performed on the structural image. An original structural image is shown
in Figure 4.2a, with grey matter (GM) segmented shown in Figure 4.2b, white matter (WM) in
Figure 4.2c and cerebral spinal fluid (CSF) in Figure 4.2d.
Everyone’s brain is different, normalization is the process by which the images are deformed
such that they all fit a standard template. Fitting everyone’s brain to a template ensures compa-
rable anatomical structures in the brain match up between participants.
The template chosen is the Montreal Neurological Institute (MNI) space. All the BOLD



















Figure 4.2: SPM segmentation of the HC participant. a Structural image. b
Segmented grey matter image. c Segmented white matter image. d Segmented
cerebral spinal fluid image.
settings were changed from defaults to match the AAL template (See Section 4.4 for AAL details).
The final process we used SPM for before exporting into 4D matrices for use within Matlab is
smoothing. The previous steps above are not perfect, and so smoothing is used to increase the
overlap areas of the brain and ensure a better match of anatomical regions between participants.
This uses a 3D Gaussian kernel with a full width at half maximum size of 8x8x8 mm3. This is
performed on all the normalized functional images. Figure 4.4 shows a smoothed BOLD image
(compare to the unsmoothed normalized image in Figure 4.3b).
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Figure 4.3: SPM normalization of the HC participant. a Realigned BOLD







Figure 4.4: Smoothed BOLD image of the HC participant.
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4.3.2 Further preprocessing in MATLAB
We converted all the smoothed functional images into a single 4D matrix for each participant.
Time series for predefined regions of interest (ROI) were extracted by averaging the BOLD
signals from all the voxels that fall within the ROI. See Section 4.4 for details on selection of
ROIs. Certain signals affect the measurement of the BOLD signal and need to be accounted for.
These signals are the movement of the participant, the BOLD signal from white matter regions
and the BOLD signal from CSF regions. The movement signals used were obtained from SPMs
realignment step (See Figure 4.1 for an example of movement signals). White matter signal was
obtained from averaging all the BOLD signals from the voxels that fall within the segmented
white matter image (see Figure 4.2c for an example of a (pre-normalized) white matter mask)
and similarly for the CSF signal (Figure 4.2d shows an example of a (pre-normalized) CSF mask).
These nuisance signals were removed using linear regression, see Section 4.3.3 for details of this.
The final preprocessing step is bandpass filtering. In the Systematic Review of Chapter 3,
we found 22/28 of the studies used a bandpass filter, with half of these using only a highpass
filter (11/22 of the studies). This removes low frequency noise attributed to properties of the
MRI scanner (termed scanner drift). However it does not remove high frequency noise attributed
to physiological signals like breathing and blood pulse, and it has been demonstrated that
connectivity is predominantly characterized by frequencies lower than these [25]. We therefore
chose the most popular bandpass range which included a highpass and a lowpass cut-off of
0.01-0.08 Hz (6/22 of the studies). The remaining studies from the review (5/22) each chose
different bandpass filter values, with varying highpass and lowpass thresholds. Figure 4.5 shows
two examples of extracted BOLD time series for two different ROIs, and those respective time



































































Figure 4.5: Example of bandpass filter applied to extracted time series from
AAL ROIs for the single HC participant demonstrated in Section 4.3.1. a
Extracted time series of AAL region 1 (left precentral gyrus). c AAL region 71
(left Caudate). b, d Series bandpassed filtered respectively, with filter range of
0.01-0.08 Hz.
4.3.3 Equivalence of linear regression and time series extraction ordering
The standard way of nuisance regression in the brain imaging community is to perform nuisance
regression on each voxel of the brain individually and then extract time series of averages of
the voxels that fall within a ROI [100]. As there are approximately O(106) voxels in a fMRI
brain image this is a potentially computationally heavy procedure. If later on in the analysis it is
decided to use different or modified nuisance signals, performing the regression multiple times
could take a long time. Extracting the time series from voxels and then performing the regression
on the extracted time series would greatly reduce computational load, as there is a maximum of
264, O(102), ROIs. It would also be more flexible, as the time series are already extracted, ready
for analysing.
The regression used is linear, which suggests that swapping the order of regression and
extraction would have no effect. However it is not immediately clear this is the case. Therefore,
we re-derived the linear nuisance regression in terms of how it is used on the fMRI data and
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prove mathematically that it is equivalent to extract ROIs and then regress nuisance signals
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where the column vector on the left represents the BOLD time signal for a single voxel or ROI
after initial preprocessing, with the value b(t) being its BOLD signal value measured at time t.
The matrix of regressor signals is composed of column vectors Ni, i ∈ [1,n], where each column
vector is the time series of nuisance signal i, with there being n nuisance regressors in total.
This regressor matrix multiplies by its weighting column vector, composed of the weightings
wi, i ∈ [1,n] determined by least squares. The final column vector is the error column vector. This
error vector is the signal we are interested in, as it is what is left of the signal after removing the
nuisance signals. The linear regression equation in a more compact form is given by
(4.2) b=Nw+ε.
The aim of the linear regression is to minimise the error ε. The most common method, and
the one used here, is by using least-squares. The derivation starts with rearranging Equation
(4.2) to make the error the subject,
(4.3) ε=b−Nw.




ε2 = ε>ε= (b−Nw)>(b−Nw)= (b>−w>N>)(b−Nw)==
=b>b−w>N>b−b>Nw+w>N>Nw
(4.4) =b>b−2b>Nw+w>N>Nw.







which we set to 0 to find the minimum, i.e.




This results in the following expression:
(4.7) N>Nw=N>b.
A visual representation of this can be found by abstracting the multidimensional column
space N onto a plane. Minimising the error in this case means finding w such that the error, ε, is
perpendicular to the N column space plane, i.e. N>ε= 0. This can thought of as taking multiple






Figure 4.6: Column space representation of least squares regression. With
BOLD signal vector b, nuisance signals N, weighting vector w and error vector
ε.
Using the column-space representation (Figure 4.6) we obtain an expression to solve,
(4.8) N>ε= 0.




and simplify, resulting in an equivalent expression to finding the minimum of the error;
(4.11) N>Nw=N>b.
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Now to define the error vector in terms of the measured signal, b, and the Nuisance regressor
matrix, N. Multiply both sides of equation (4.7) (and equivalently equation (4.11)) by the inverse








We next define K= (I−N(N>N)−1N>). Then, we obtain
(4.16) ε=Kb,
where the matrix K is a constant, defined by the nuisance regressor matrix.
We want to show that regressing every voxel and then extracting signals from them is
equivalent to first extracting signals and then regressing the extracted signals. We do this by
considering voxels we want to extract and regress, and term them bm where m ranges from
1 to M. The first case considered is regressing each voxel separately, and then extracting the
average of them. Each voxel is regressed separately and is given by εm =Kbm. The average of













The second case is where the average of the voxels is taken and then regressed. The average
of the voxels is given by 1M
∑M
1 bm, and regressing these given by









Equations (4.17) and (4.18) are mathematically equivalent. Therefore it is more computation-
ally efficient to first extract ROI time series, and then to perform nuisance regression. We apply
nuisance regression to our analysis in the more efficient way described here.
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4.4 Regions of interest (time series extraction)
We used a region of interest (ROI) analysis to explore neuroplasticity via functional connectivity
(FC) with three different sets of ROIs considered, termed Fair, Cole and AAL. All three system
of ROIs encompass the whole brain, enabling the exploratory analysis of large scale network
disruption. The AAL contains ROIs belonging to the basal ganglia, enabling the testing of the
disrupted basal ganglia hypothesis.
Fair and Cole base their ROIs inspired by a large collation of evidence which suggests the
brain can be subdivided into functional networks, shown to be involved in distinct processes
within the brain [90]. For Fair and Cole we define their ROIs as spheres located as stated in their
studies, with radii of 4mm. We extracted time series as the mean of all the voxel BOLD time
series that fall within each respective ROI sphere.
Fair based their networks on previous studies, manually collating positions for all the nodes
from their networks of interest. They define 30 ROIs belonging to 3 distinct networks: the fronto-
parietal network (FPN), the cingulo-opercular network (CON) and the default mode network
(DMN). The FPN and CON are involved in task control [37, 38], where the FPN supports top-down
(in the moment) maintenance of task performance whilst the CON primes and sustains the brain
in a task state [36]. The DMN is comprised of regions consistently shown to be correlated at rest
in adults, and is reported to be involved in autobiographical, self-monitoring value judgements
and other self-referential mental activity [56, 90, 119].
Cole [24] is similar to Fair, i.e. based on resting-state functional networks, except it defines
location of its nodes differently, and has more of them. Cole based the locations of their ROIs on a
previous study [118] which performed an analysis on a large fMRI dataset to identify voxels that
significantly changed when certain behaviours or stimuli were presented. The study combined
this with a mapping process which treated the cortex of the brain as a 2D sheet, and identifies
areas where patterns in the BOLD signal rapidly change. These areas represent boundaries
between different functional networks. Cole define 264 ROIs belonging to 11 distinct functional
networks: the auditory network, CON, dorsal attention network (DAN), DMN, FPN, the salience
network (SAN), the somatosensory network (SMN), a subcortical network, an uncertain network,
the ventral attention network (VAN) and visual network. The FPN, CON and DMN are defined
by both Fair and Cole, although Cole report more ROIs belonging to each of them. The function
of these have been discussed above. The SMN is involved in multiple senses including pain,
temperature, touch and limb position [9]. The SAN is involved in identifying what signals in the
brain are most relevant for further processing and focus [91, 134]. The DAN and VAN are in-
volved in attention, mediating voluntary focus on locations or features and detecting unexplained
stimuli [152]. Auditory and visual networks are, as their names suggest, involved in listening
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and vision. The subcortical network was a coherent functional network structure found within
the subcortical areas of the brain, and the unknown network was a network their analysis found
which could not be identified as any previous known functional network.
In contrast to Fair and Cole, the automated anatomical labelling (AAL) atlas [149] is a system
of ROIs based solely on anatomy, not function, comprised of 116 regions. Figure 4.7 shows a mid
sectional slice of the AAL atlas, where each colour represents a different anatomical region. We





Figure 4.7: Axial slice of the AAL atlas produced from AAL mask in MATLAB;
different colours represent different anatomical regions.
4.5 Network analysis methods
Functional connectivity (FC) is a statistical measure of how correlated the BOLD signal of two
regions is, with a higher FC inferring greater communication. We measured FC using Pearson’s
correlation coefficient, pairwise for every ROI, resulting in a connectivity matrix for each partici-
pant. This matrix can be analysed as an adjacency matrix, describing a functional brain network.
We kept the weightings of the network, rather than applying a threshold and transforming it
into a binary network, because choosing a threshold has been shown to be ambiguous [33, 66].
One way to visualize how Pearson’s correlation captures FC is to plot the BOLD values of one
time series against another. Figure 4.8 shows four BOLD against BOLD plots along with their
corresponding Pearson correlation coefficients, demonstrating different FC.
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Figure 4.8: Visual representation of Pearson’s correlation between a selection
of different AAL ROIs. This is for the HC participant with a scanning time of
4.53 minutes, i.e. 300 volumes.
We applied the Fisher transform to the matrix to improve normality, defined as








where r is the input correlation coefficient and z is the transformed value. Correlation coefficients
are bound between −1 and 1; if a number of sample correlations are near these bounds their
distribution would be skewed. Applying the Fisher transformation removes these bounds and
preserves variance across the correlation coefficient range; resulting in approximately more
normal values.
Correlation coefficients can be both positive and negative. However, in fMRI there is little
consensus as to the interpretation and how to handle negative FC weights [58]. This review
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additionally searched resting-state studies and found a mixture of how they handled negative
weights; with 57% reporting no or insufficient information on what they did, 21% discarded
negative weights, 9% took the absolute value, 8% kept them and 5% did some other transformation.
Due to this uncertainty we take the absolute value of the correlation as the FC measure, and
argue that two strongly negatively correlated regions are still strongly functionally connected. Of
note, for one part of our network analysis we do look at negative weights; see Modularity prior in
Section 4.5.1.
4.5.1 Network measures
We looked at the following network properties to compare between the two populations. These
network measures were part of the exploratory analysis; apart from basal ganglia connectivity,
which was hypothesis driven.
Clustering coefficient
If two strongly connected neighbours of a node are themselves likely to be strongly connected
to each other, the network is said to have a high clustering coefficient. This coefficient, C, is
calculated as the average of all the local clustering coefficients, ci, across all N nodes given by





Defining the local clustering coefficient, ci, is straightforward in binary networks, defined
as the fraction of immediate neighbours also connected. Three extensions to weighted networks
were explored by [97], with three differently defined local clustering coefficients. Onnela [109]










The coefficient defined by Barrat [8] is
(4.22)










and the formulation by Zhang [167] is given by
(4.23) ci,Z =
∑
j,k ŵi jŵ jkŵik(∑
k ŵik
)2 −∑k (ŵik2) ,
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where wi j is the strength of the connection between nodes i and j, ŵi j = wi j/max(w), ki is the
number of edges connected to node i, and ai j = 1 if there is a connection between nodes i and j,
otherwise it is 0. We only used Onnela’s clustering coefficient because Barrat’s one is used for
networks which are not fully connected which is not the case with our network and Zhang’s was
developed in the context of gene expression networks, not functional brain networks.
Characteristic path length
The path length is defined as the ability for information to flow, directly or indirectly, between
any two nodes; with shorter path lengths meaning flow is easier. The characteristic path length
of a network is the average of all the path lengths in the network. The distance of a path between
two regions should be short if the two nodes are more functionally connected. Since higher FC
implies greater connectivity, distance was defined as the inverse of the connection strength, i.e.
(4.24) di j = 1wi j
,
where wi j is the FC between nodes i and j and di j is the new defined path length between them.
Characteristic path length is the average of all the pair-wise distances, given by






A network which displays small world properties simultaneously has large clustering coefficient
and short characteristic path length [154]. However this formulation is for binary, unweighted
networks. We used an extension to weighted networks [97], which calculates the weighted small-
world propensity (w-SWP) by seeing how an input network deviates from two null models with
equal weighting distribution and number of nodes. The null models are a lattice network, which
have the highest clustering coefficients; and a random network, which have the shortest charac-
teristic path lengths.
The fractional deviation of the clustering coefficient and characteristic path length from the
null models are given respectively by




CHAPTER 4. ANALYSING LARGE SCALE FUNCTIONAL NETWORKS IN MULTIPLE
SCLEROSIS
(4.27) ∆L = Lobs −Lrand
Llatt −Lrand
,
where Clatt and Llatt are the clustering coefficient and average path length of the lattice network
respectively, Crand and Lrand are for the random network and Cobs and Lobs are for the input






Some networks can sometimes exceed lattice and random networks for the clustering coefficient
and characteristic path length respectively. Therefore these fractional deviations (∆C and ∆L)
are capped between 0 and 1.
Modularity
The modularity quantifies the extent to which a network can be subdivided into densely connected
regions called communities [47]. By construction, the FC within communities tends to be large
and that between different communities small. We looked at two different modularity measures;
one which finds the modularity of an optimized segregation of the whole network, and another
which measures the modularity of the network already subdivided, based on prior labelling into
distinct functional groups. These will be referred to as modularity optimized and modularity
prior respectively. We calculated modularity optimized using code from the Brain Connectivity
Toolbox [125], whose modularity optimized algorithm is based on prior work from [103, 104, 120].
Modularity prior was based on algorithms developed by [126], whose focus was on network
measurements specifically for weighted functional brain networks. Modularity prior is given by




(wi j − e i j)δMi M j
where v = ∑i j wi j, e i j = si s jv , si = ∑ j wi j and s j = ∑i wi j. For these calculations wi j is the FC
value between ROIs i and j and δMi M j is equal to 1 if ROIs i and j belong in the same module,
otherwise it is 0.
An alteration to this modularity measure takes into account negative weights as well [126]. A
high modularity for this measurements means a network displays high positive within module
connectivity and high negative between module connectivity. Their reasoning is that positive FC
values represent similar activation patterns, hence warranting placement in the same module
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and negative FC values represent distinct, antiphase coupling, hence placement in different
modules. The calculation for the modularity from positive weight contributions is given by




(w+i j − e+i j)δMi M j
where v+ = ∑i j w+i j, e+i j = s+i s+jv+ , s+i = ∑ j w+i j and s+j = ∑i w+i j. Here w+i j = |wi j| if wi j > 0 otherwise
w+i j = 0. Similarly, for the negative weights contributions the modularity is calculated as




(w−i j − e−i j)δMi M j
where v− = ∑i j w−i j, e−i j = s−i s−jv− , s−i = ∑ j w−i j and s+j = ∑i w+i j. Here w−i j = |wi j| if wi j < 0 otherwise
w−i j = 0. The total modularity, taking into account positive and negative weights and based on
prior module labelling, is calculated as





The basal ganglia, as defined in the AAL, is comprised of six regions. The left and right Caudate,
left and right Putamen, and left and right Pallidum. We define the basal inner connectivity as
the average FC over the 15 region pairs within the basal ganglia. Basal outer connectivity was
defined as the FC between a basal ganglia region and a region outside the basal ganglia, averaged
over 6×110= 660 such region pairs. We defined outer-outer connectivity as the average of the FC
over the remaining 5,995 region pairs outside the basal ganglia.
4.5.2 Individual basal ganglia region analysis and single threshold
permutation correction
We performed t-tests of the FC on each of the 15 region-region pairs within the basal ganglia
separately, i.e. FC between left Putamen and right Putamen, FC between left Putamen and Left
Pallidum etc.
With the individual basal ganglia connectivity analysis there is now a multiple comparisons
problem, as it is comprised of 15 simultaneous statistical tests. Therefore, some form of multiple
comparisons correction is needed. The multiple comparison correction we used is based on a
permutation procedure [106], set out below. Rather than the p-value, the correction uses the
t-statistic from each test, which is a standardized measure of the difference of means between
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two populations. We performed this particular correction because it is non-parametric (so no
parameters need fitting or altering) and it does not over-zealously correct every positive test (i.e.
it is more ‘forgiving’).
The procedure is as follows:
1: From the MS labels and HC labels, randomly assign them to each participant, effectively
shuffling who is labelled as MS or HC, whilst keeping the size of the two groups the same.
2: Perform basal ganglia analysis, measuring t-statistic for each region-region pair. A positive
t-statistic means the FC between those two regions is greater in HC than MS. A negative
t-statistic is the inverse (i.e. MS > HC).
3: Across all the region-region pair test results (total of 15) record the highest value (labelled
Tmax) and the lowest value (labelled Tmin).
4: Re-shuffle the participant labels as in the first step, and repeat the analysis. This results in
distributions of the maximum and minimum t-statistics across random shuffling of labels.
5: Corrected p-value of a region-region pair for HC>MS is the proportion of values in the
permuted Tmax distribution greater than the actual t-statistic for that region-region pair.
For MS>HC it is the proportion of values in the permuted Tmin distribution less than the
actual t-statistic.
4.6 Network analysis results
In summary, the network measures we looked at were:
• Clustering Coefficient.
• Characteristic Path Length.
• Weighted small-world propensity (w-SWP).
• Modularity Prior - Absolute Weights (Fair and Cole only).
• Modularity Prior - Positive and negative Weights (Fair and Cole only).
• Modularity Optimized.
• Number of modules found from Modularity Optimize.
• Basal Inner. (AAL only).
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• Basal Outer. (AAL only).
• Outer-outer. (AAL only).
We measured each network property for each participant and compared the properties
between HC and MS using un-paired t-tests. This results in a p-value for each network property,
representing similarity between the two groups. Table 4.2 shows the p-values for each network
property, and for each relevant system of ROIs they fall within. Using a significance level of 0.05
we found only one significant result across all the systems of ROIs and network measures, that of
basal inner mean connectivity with a p-value of 0.0177 (HC > MS).
ROIs
Network Measure Fair Cole AAL
Clustering Coefficient 0.876 0.388 0.506
Characteristic Path Length 0.894 0.543 0.928
Weighted Small-world propensity 0.592 0.842 0.967
Modularity Prior (Absolute) 0.0964 0.934 -
Modularity Prior (Positive and Negative) 0.179 0.729 -
Modularity Optimise 0.914 0.329 0.493
Number of optimised Modules Found 0.566 0.324 0.476
Basal Inner Mean connectivity - - 0.0177
Basal Outer Mean connectivity - - 0.850
Outer-Outer Mean connectivity - - 0.961
Table 4.2: P-values from unpaired t-tests for different network measures, and
different systems of ROIs, between MS and HC populations (0.01-0.08 Hz
bandpass filter). Network measure not being applicable to the system of ROIs
is indicated by a dash (-).
4.6.1 Individual basal ganglia region results
The average inner FC within the basal ganglia was found to be significantly different between HC
and MS participants, prompting a more detailed investigation. Therefore we performed region by
region FC analysis within the basal ganglia. Figure 4.9 shows a heatmap of p-values for each
of the respective pairs, Figure 4.9a is all the p-values for which the FC of the region pairs was
found greater in HC than MS, and vice versa for Figure 4.9b (i.e. MS greater than HC).
Only one region-regions pair’s FC was found to be greater in MS than in HC, that between the
left and the right Caudate. However this was not significant with a p-value close to one. For HC
greater than MS four of the p-values were below 0.05: between left Putamen and right Putamen,
left Putamen and right Pallidum, right Putamen and right Pallidum, and between left Pallidum
and right Pallidum.
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Figure 4.9: Individual Basal Ganglia regions FC t-test colourmap. KEY: 1.
Left Caudate, 2. Right Caudate, 3. Left Putamen, 4. Right Putamen, 5. Left
Pallidum, 6. Right Pallidum.
Significant results were found within the basal ganglia, but with 15 simultaneous statistical
tests a multiple comparisons correction is needed. We performed the correction as set out in
Section 4.5.2. Figure 4.10 shows results of the multiple corrections, displaying the distributions
of the randomly shuffled Tmax and Tmin values in blue, along with the actual t-statistic values
as red flags. Figure 4.10a shows the distribution of Tmax values, significant region-region pairs
would have their actual value (red flag in figure) greater than the distribution (i.e. to the right).
Most of the actual values are firmly within the distribution, with the two furthest to the right
having corrected p-values of 0.0639 and 0.0767. Figure 4.10b shows the distribution of Tmin
values, where significant region-region pairs would be to the left of the distribution. No value
here is remotely significant, with the lowest corrected p-value being 0.941.
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Figure 4.10: Distributions of random permutations of participant labelling
used for multiple corrections. Distribution values are the maximum (a) or
minimum (b) t-statistic measured across all 15 basal ganglia statistical
comparisons for each permutation. Red flags plotted on top are the actual
t-statistic values measured.
4.7 Correlations with clinical markers
The systematic review of Chapter 3 highlighted how a majority of the studies found performed
correlations of a FC metric and some form of clinical marker, i.e. a test score (see Section 3.3.8).
Our collaborators measured a number of test scores and clinical markers which we used to
correlate with our network measures. A significant correlation between a network measure and
one of the test scores or clinical markers could show evidence of compensatory neuroplasticity,
even though none of the network measures themselves were significantly different between MS
and HC. We performed this analysis using Pearson’s correlation coefficient of each score against
each network measure, for MS and HC separately. This results in a coefficient value and a p-value
for each correlation.
The Clinical markers measured were: Age, CSF, D2 Error, D2 Speed, FSS, GM, Interference,
Naming, T2, T2 RT, T3, T3 RT, Trail A, Trail B, WM and Words; a total of 16 markers.
CSF, GM and WM are cerebral spinal fluid, grey matter and white matter volume respectively.
FSS is the fatigue severity scale, a questionnaire to evaluate the impact of fatigue. T2 and T3
are the tasks carried out in the scanner as part of the task based portion of the study; where T2
RT and T3 RT are the their respective reaction times. T2 was measuring intrinsic alertness and
T3 was extrinsic. D2 Error and D2 Speed are part of a cognitive test called D2, measuring their
error and speed performing this respectively. Naming, Interference and Words are part of the
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Stroop test, used to assess cognitive interference, and can be used to measure other multiple
cognitive functions [128]. Trail A and Trail B are hand written attention tests. These later tests
(D2, Stroop, Trail A, Trial B) were carried out before and after the scan.
All this analysis was carried out in an exploratory manner; apart from correlations with the
FSS, which is part of the hypothesis involving fatigue. Of note, other clinical measures displaying
significant correlation with FC could still be interrupted back to fatigue, though it would be a
weaker, indirect relationship.
For HC with Fair ROIs; out of 112 correlations (16 markers multiplied by 7 network measures),
5 had p-values less than 0.05, with the lowest value being 0.0147. With Cole ROIs 9 out of 112
(16 markers multiplied by 7 network measures) had a p-value less than 0.05, with the lowest
being 0.00432, and for AAL ROIs 12 out of 128 correlations (16 markers multiplied by 8 network
measures) passed the significance threshold, the lowest being 0.000117. For MS with Fair ROIs
10 out of 112 correlations passed significance, the lowest value being 0.0102; with Cole ROIs 6
out of 112 were lower than 0.05, the lowest being 0.0136. Finally, with AAL ROIs 7 out of 128
were significant, the lowest being 0.00897. CRICBristol recruited MS participants because of
their fatigue. However none of the significant correlations were with FSS scores. We observed
no clear tendency in these results, though some were lower than 0.05. However, none of these
correlations are likely to pass multiple comparisons corrections, and those that did would require
further interpretation to infer what physiological meaning they may have.
4.8 Preprocessing protocol alterations
The preprocessing protocol can affect group discrimination, as well as signal-noise separation and
test-retest reliability [136]. This inspired us to look at how altering some of the preprocessing
used might affect the significance of any differences found in network properties between the
two populations. We looked at altering the nuisance regression signals and at the bandpass filter
threshold values.
4.8.1 Nuisance regression alteration
Two of the studies found in the systematic review of Chapter 3 [60, 170] included the first time
derivative of the nuisance signals in their regression. We did the same, with the results in Table
4.3. Comparing to the results with no first time derivative included, Table 4.2, no non-significant
previous value has turned significant. However the single previous significant difference found,
that of the basal inner, has had its p-value increase from 0.0177 to 0.0799, which is now considered
non-significant.
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ROIs
Network Measure Fair Cole AAL
Clustering Coefficient 0.904 0.426 0.909
Characterstic Path Length 0.777 0.801 0.788
Weighted Small-world propensity 0.133 0.622 0.828
Modularity Prior (Absolute) 0.0901 0.974 -
Modularity Prior (Positive and Negative) 0.0996 0.505 -
Modularity Optimise 0.904 0.325 0.708
Number of optimised Modules Found 0.285 0.683 0.628
Basal Inner Mean connectivity - - 0.0799
Basal Outer Mean connectivity - - 0.769
Outer-Outer Mean connectivity - - 0.878
Table 4.3: P-values from unpaired t-tests for different network measures, and
different systems of ROIs, between MS and HC populations (0.01-0.08 Hz
bandpass filter). Including 1st time derivative of nuisance signals to regressors
(compare to results in Table 4.2). Network measure not being applicable to the
system of ROIs is indicated by a dash (-).
4.8.2 Bandpass parameter space
For all the previous analysis (results in Section 4.6) we used a fixed bandpass filter of 0.01-0.08
Hz. Previous studies have looked at how different frequencies contribute to FC [25, 160]. We
therefore looked at how bandpass filter values affect the significance of differences between HC
and MS over all the previous network metrics. We repeated the analysis using different values for
the bandpass filter thresholds and recorded the p-value for each respective value. We used a range
of no highpass to 0.05 Hz for the high pass cut off, and 0.06 to no low-pass for the low-pass cut off
value. This resulted in a heat-map of p-values over the bandpass parameter space, representing
significance of difference between HC and MS. The darker blue values represent there being
a greater significance of difference between the populations, and lighter yellow values are for
less significant differences. This shows significance, but not whether the measure is showing
the value being greater in MS, or in HC. We plotted the p-values against their corresponding
difference of the mean in measurement (mean HC minus mean MS) to check against a scenario
in which a majority of the bandpass space is significant (i.e. mostly blue with majority of values
less than 0.05), but a mix of significant values being MS greater than HC and vice versa.
Figure 4.11 shows the results of the bandpass space analysis for the clustering coefficient.
Figure 4.11a is for Fair ROIs and shows that a majority of the p-values over the parameter space
are large (mostly yellow). The red dots superimposed on this image are the different bandpass
parameter values we found from the review in Chapter 3. Two of the values were outside the
range we explored and are placed outside at approximately the location they correspond to. One
of these (top right) was for a study designing a classifier and the other (bottom left) was focusing
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on low frequency signals. These values are the same for all the bandpass space figures, and are
only shown in this particular case for reference. Figure 4.11c is for Cole ROIs and Figure 4.11e
for AAL ROIs; for both of these systems of ROIs there is a mix of significance across the bandpass
space, though no areas are significantly dark. Figures 4.11b, 4.11d and 4.11f all show an even
spread of p-values for MS greater than HC and vice versa for Fair, Cole and AAL respectively.
This signifies no significant difference of this measure between HC and MS.
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Figure 4.11: Bandpass parameter space results for the clustering coefficient.
a,c,e Heatmap of p-values over a bandpass parameter set of values for Fair,
Cole and AAL respectively. Red dots of a are parameter values found from the
review in Chapter 3. b,d,f All points in heatmaps p-values plotted against the
difference of mean that produced the respective p-value, for Fair, Cole and AAL
respectively.
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Figure 4.12 is the bandpass space analysis results for weighted small-world propensity. Figure
4.12a for Fair ROIs shows significance varies greatly. Figure 4.12b shows that a portion of the
values are significant and that all significant bandpass values show w-SWP being greater in MS
than in HC. When referring back to Figure 4.12a all the significant values (dark blues) are from
the top right of the bandpass space, not a region commonly used (as found from the systematic
review). Figure 4.12c is for Cole ROIs and shows the significance between HC and MS varies
greatly over the bandpass parameter space, with some parts (slice across the middle) falling
below 0.05. Figure 4.12d shows all the significant values show the MS having greater w-SWP
than HC. However, large parts of the space are still non-significant reducing confidence in this
being a significant result. For AAL ROIs, Figure 4.12e shows varying significance across the
parameter space, with the greatest significance at the top left corner. Figure 4.12f shows all the
highly significant values all show MS having greater w-SWP than HC. However it also shows
that most of the values are still not significant.
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Figure 4.12: Bandpass parameter space results for the weighted small-world
propensity. a,c,e Heatmap of p-values over a bandpass parameter set of
values for Fair, Cole and AAL respectively. b,d,f All points in heatmaps
p-values plotted against the difference of mean that produced the respective
p-value, for Fair, Cole and AAL respectively.
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Figure 4.13 is for basal inner, with Figure 4.13a showing the whole bandpass space to be
dark blue, implying significance. Figure 4.13b shows that all the values are showing HC having
greater basal inner connectivity than MS, with all the values clustered at the bottom right. This
figure indicates that, although not all the values are below 0.05, a large proportion are.
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Figure 4.13: Bandpass parameter space of basal inner measurement (AAL). a
Heatmap of p-values over a bandpass parameter set of values. b All points in
heatmaps p-values plotted against the difference of mean that produced the
respective p-value.
We explained the results of the bandpass space analysis for the clustering coefficient, weighted
small-world propensity and basal inner only. All the other networks measures resulted in no
significant results, and qualitatively looked the same as for the clustering coefficient, i.e. mostly
insignificant p-values corresponding to a mix of MS greater than HC and vice versa.
4.9 Discussion
We found no significant difference between MS and HC with any of the network measures we
looked at. This could be because the cohort of MS brains studied have already successfully
undergone neuroplasticity to compensate for the damage caused.
Disruption to the basal ganglia has been widely reported to cause fatigue, which the MS
participants recruited report as a common symptom of theirs. We found the average of all the
basal ganglia’s inner FC connections to be significantly different between HC and MS participants.
This initially appears as good evidence as to a possible cause of the MS participants fatigue.
However this significance was not preserved when analysing the individual connections and
correcting for multiple comparisons. Additionally the mean inner FC of the basal ganglia was not
significantly different when adding the first time derivative of the nuisance signals to regress,
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reducing the confidence that there is a disruption to this part of the brain in the MS participants.
A better ROI parcellation of the basal ganglia, representing a finer more course grain volume
definition, may elucidate if there is any disruption. A further analysis we could perform to help
validate these results is dynamic causal modelling (DCM) [49]. DCM is a method used to estimate
directed adjacency matrices, i.e. whether a region directly influences another region. This method
is suited for analysing a small number of regions, ideal for the six of the basal ganglia. A model
is hypothesized describing how regions directly affect other regions, and DCM calculates how
well the data fits the model. For the case here, based on our knowledge of what links we believe
to be affected by MS, we could put forward two models of how the basal ganglia connects. One
would be how the basal ganglia is thought to work in healthy populations, i.e. a “healthy model”,
and the other how we believe the connectivity of the basal ganglia may have been affected by
MS, i.e. a “disrupted model”. These models would both be run with HC and MS participants
and if it is shown that the HC population fits the “healthy model” better than MS, and the MS
population fits the “disrupted model” better than HC then this could be evidence of disruption to
those particular links. This would require the models to be formulated before the DCM analysis
could be run.
At the frequency band we chose, 0.01-0.08 Hz, Small-world propensity did not significantly
differ between HC and MS. A study showed Small-world features in fMRI data to be most salient
at lower frequencies (0.03-0.06 Hz) [5]. However when looking at the bandpass space results none
of the system of ROIs showed significance of w-SWP at these frequencies, though they did at other
frequencies; with Fair ROIs we showed significant differences at approximately 0.05-0.09 Hz,
with Cole ROIs at 0.025-0.09 Hz and with AAL ROIs at around 0.05-0.065 Hz. The discrepancies
in these values, and the fact that w-SWP for most of the bandpass space was still not significant
reduces the confidence in there being any difference between the function of the brains of HC and
MS in terms of small world saliency.
We chose to use Pearson’s correlation coefficient to measure FC. This is an arbitrary choice
and other measures do exist such as Spearman’s correlation or mutual information, as found in
the review of Chapter 3. However, the different measurements qualitatively measure the same
thing: correlation between time series. Another possible way to measure FC would be by using
partial correlation, measuring the correlation between two ROI time series whilst controlling for
the correlation between all the rest of the ROIs.
The time series of each ROI are the average of the time series of a group of voxels, which are
themselves the average measure of the BOLD signal of many brain cells. Each ROI time series
could have a different variance depending on the voxels they were sampled from, especially for
the AAL atlas whose different anatomical regions are different sizes and therefore comprised of a
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different number of voxels. Analysing the variance of each time series could shape a different
interpretation of any results that may be produced.
We found no evidence for what may be causing the reported fatigue of the MS participants,
and with no network measure significantly differing between MS and HC, no mechanism can be
put forward to its possible cause. Furthermore none of the measures significantly correlated with










A METHOD OF CHARACTERIZING DYNAMIC FUNCTIONAL
CONNECTIVITY IN FMRI
As discussed in Chapters 3 and 4, functional connectivity (FC) is a statistical measure ofcorrelation between two regions of the brain, with higher FC inferring greater communi-cation between the regions. When previously calculating the FC between two BOLD time
series we used the Pearson’s correlation coefficient over the entire time series. This is termed
static FC and is an average of the FC between two regions over that time. The brain is dynamic
and averaging over the whole time series could miss out important dynamics [21].
In this chapter we are interested in how the FC between two regions changes over time,
rather than what its FC over that whole time period is. This measurement is called dynamic
FC (rather than static FC) and there are different methods to calculate dynamic FC, with a
recent review [163] outlining seven of them. Instead of outputting a single FC value, as for static
FC, dynamic FC returns a time series of the changing FC over time. This presents a problem
in terms of how to analyse and characterize the connectivity, which although lots of methods
exist to analyse time series [79] these measures are not immediately applicable to dynamic FC.
We wanted to investigate dynamic FC, using the Kalman filter as a potential tool for future
research. We chose the Kalman filter because they are ideally suited to infer underlying trends or
properties in noisy data, ideal for fMRI. Kalman filters are predict and update algorithms used
for smoothing and estimation of parameters in many diverse fields [166].
We are aware of of one study which used a Kalman filter for magnetoencephalography (MEG)
data [148]. However, to our knowledge no such analysis has been performed on dynamic func-
tional connectivity with fMRI.
135
CHAPTER 5. A METHOD OF CHARACTERIZING DYNAMIC FUNCTIONAL CONNECTIVITY
IN FMRI
5.1 Methods
The Kalman filter works by combining the output of an underlying model at a certain state
with external data measured at that state. This process is carried out sequentially with each
subsequent state. Figure 5.1 demonstrates how the Kalman filter works, where a state (red circle)
is updated via its underlying model (to a blue circle), and combined with data (fuzzy circle) at
that state to output a better estimate for that state. This new state can then be updated and









(state i filtered 
with data i)
State i+2 
(state i+1 filtered 
with data i+1)
Figure 5.1: Representation overview of how a Kalman filter works. States (red
circles) are updated via an underlying model (to a blue circle) and combined
with data (fuzzy pink circles) for a better estimate of the state.
We apply the Kalman filter to fMRI via calculating dynamic FC, where the FC between two
regions is the state. The system we are analysing here is 1-dimensional, that dimension being FC.
We assume a simple underlying model where there is no change from one state to the next. This
assumption is used because the data is from resting-state, i.e. no external influences, and this
chapter is preliminary work. These methods could be extended to task based fMRI data, where
the underlying model update would be correlated with the task.
We used a simple moving window method to calculate dynamic FC, as the Kalman Filter
proposed here should be able to be applied to different methods of calculating dynamic FC.
Figure 5.2 shows how the moving window method works in calculating dynamic FC. Figure
5.2a shows two BOLD time series (blue) with a moving window (red). The two series are extracted
from the Left Caudate and Right Caudate from a HC participant. The width of the window in
this demonstration is 15 time to repetition (TR) units; TR is the sampling rate of fMRI, used as
the time scale here. Pearson’s correlation is performed between all the BOLD values within this
window, and Fisher transformed. The window is moved along one time step and the calculation is
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repeated. Figure 5.2b shows the resulting dynamic FC as the window is moved along, displaying
how the connectivity between these two regions is dynamic over time.
a Two BOLD time series

















b Dynamic FC between BOLD series






















Figure 5.2: Moving window method for calculating dynamic FC. Moving
window (red bar) moves left to right. a Two example time series to calculate
dynamic FC of. Pearsons correlation is calculated within the moving window
and Fisher z-transformed, with value recorded down as correlation at time
halfway in the window. b Snapshot of Dynamic FC between example BOLD
time series up to the moving window.
The Kalman filter is applied to the dynamic FC between two ROIs time series, for a single
participant. Each moving window correlation value is the new data on which the filter updates.
The filter starts with an initial guess of the FC, and with each iteration (as the time window
scans across) updates this guess using each subsequent value from the dynamic correlation. The
starting prior could be anything, and future work would need to be carried out to explore how this
effects its performance. As we are neglecting the underlying model in this analysis, the Kalman
update process demonstrated below is simpler than it would have been including an underlying
model.
The Kalman filter updates using a Bayesian method, assuming all the data is normally
distributed. Figure 5.3 shows a schematic to illustrate how the distributions of data and prior
update to the posterior, displaying a distribution for an initial guess (prior in red), along with
distributions for the data (blue) and the updated measurement for the value (posterior in yellow).
After the measurement estimate has been updated with a step of the Kalman process, and since
we have neglected the underlying model, the posterior distribution then becomes the prior of the
next iteration.
The update of these distributions is done by looking at the means and variances of all
the distributions involved. The mean and variance of the update measurement (posterior) is
calculated using the Kalman gain:
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which is used to define the posterior mean:
(5.2) µN =µP +K(µD −µP ),
and the posterior variance:
(5.3) σ2N = (1−K)2 σ2P +K2 σ2D ,
where K is the Kalman gain; µN and σN are the updated mean (posterior mean) and updated
standard deviation (posterior s.d), respectively; µP and σP are the starting mean (prior mean) and
starting standard deviation (prior s.d), respectively; and µD and σD are the mean and standard
deviation of the incoming information (data mean and data s.d), respectively.
The Kalman gain, K, works such that if a new measurement has a very small variance there
is greater certainty in its value, which draws the posterior mean µN closer to it. The inverse is
true for a high variance, which has greater uncertainty and therefore the posterior mean µN will
remain closer to the prior. As for the updated variance, each update qualitatively averages the
variance of the prior and the data such that as long as both σD and σP are sufficiently small the
138
5.2. RESULTS
new variance σP will become smaller with each update.
Each subsequent measurement of the FC within each time window was measured using
Pearson’s correlation coefficient. This value is bound between −1 and 1 and is not normally
distributed. This is why Fisher’s z-transform was applied to each correlation measurement, which
normalizes Pearson’s correlation coefficient. The new Fisher z-transformed value becomes the
mean of the data distribution. For its variance, Fisher’s transform has the property that when
applied to a bivariate normal distribution the standard error is simply a function of the number
of data points used to calculate the correlation: 1p
N−3 , where N is the number of data points
within each window. Figure 5.4 shows distributions of the BOLD values for two example ROIs,
which appear normally distributed. This demonstrates that the correlation coefficient comes from
a bivariate normal distribution, and that we are justified in assuming that the BOLD values are
normally distributed. We therefore use Fisher’s standard error as the value of σD in each update.


















Figure 5.4: Distributions of the BOLD values for the two example ROI time
series respectively.
5.2 Results
The Kalman filter applied to the FC between the same two example ROIs as before (i.e. left and
right Caudate of a HC participant) is shown in Figure 5.5, displaying the dynamic correlation
(blue) with the Kalman filtered correlation (red) along with the static correlation (dotted black
line). This result was produced with a time window size of 10 TRs.
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Figure 5.5: Dynamic correlation (blue) and Kalman output (red) with a
window size of 10 TRs. Black dotted line is original FC calculation of entire
time series at once.
The results for four different sizes of time window are shown in Figure 5.6. As for with a
window size of 10 TR the filter works as a smoother, tracking the broad changes in FC over time.
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a Window size = 15















b Window size = 20















c Window size = 25















d Window size = 30















Figure 5.6: Dynamic correlation (blue) and Kalman output (red) plots with
varying window size. Black dotted lines are original FC calculation of entire
time series at once. Starting prior mean and variance (i.e. at Time 0) is the
mean and variance of every point in the dynamic FC (blue line). Future work
will be in exploring different starting values.
We tested the filter by measuring the value at the end of the Kalman process, i.e. the value
produced by the Kalman filter at the end of the time series. We chose the end value as a statistic
to explore because it has taken all the information over the course of the time series and may
output possible insights into the filters performance. We explored how the window size affects
the Kalman filter results, over a greater range of window sizes, by recording the mean and
variance at the end of the Kalman process and plotting it against the window size which produced
it. Figure 5.7a shows how the end mean is affected by varying window size, and Figure 5.7b
shows how it affects the end variance. This shows how faster transient dynamics can affect
the correlation measured, as seen with the decrease in the end FC with smaller time windows
(valley around 0-50 TRs wide in Figure 5.7a). As for the variance, with greater window size
there are less measurements, and so the Kalman filter has less information on which to converge.
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However with smaller window sizes each measurement has more uncertainty even if there are
more measurements. Figure 5.7b shows this interplay between having less measurements each
with smaller variance and more measurements each with greater variance, reaching a minimum
end variance with a window sizes of approximately half the full time series length. A desired
behaviour may be to find an output value with the least uncertainty. Using the end Kalman value
as an output would require using a window size half the entire time series length to minimize its
variance. However this would not necessarily be the best choice as it could miss out on the faster
transient dynamics.
a End mean against window size
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Figure 5.7: How the end of the Kalman process is affected by window size.
Same single participant and ROIs as all other results in this chapter. a How
mean of final Kalman estimate of the FC is affected by changing window size.
b How the variance of the final Kalman estimate of the FC is affected by
changing window size.
5.3 Discussion
This chapter has presented preliminary work on investigating conceptual tools to analyse dy-
namic FC via a Kalman Filter. It has not been used yet in analysing real world data and this
chapter gives only an example between two time series. We show that the filter can track the
broad changes in dynamic FC over time, and that considering faster dynamics with smaller
window sizes can affect the results. Generalizing to other ROIs could throw up unpredictable
behaviours that would require adjustments to the filter.
Future work on this would be to investigate how the starting mean and starting variance
affect this Kalman process. Another area of research would be a more rigorous justification for
choice of window size, as well as how a different window shape could affect the outcome. These
questions have been researched in a recently published paper [95] applied to dynamic FC (though
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not Kalman filters), and applying their findings to how the Kalman filter has been implemented
here could be interesting.
Using a cumulative average of the dynamic FC would in this case have given very similar
results. However the Kalman filter may out perform these in the case of when a signal is changing,
as is the case in dynamic FC. Furthermore, for the example ROIs shown the Kalman filter acts
qualitatively as a low-pass frequency filter. Moving averages and low-pass filters are an estimate
of a measure part way to the current time, i.e. in the past. The Kalman filter would be an estimate
at the current time, i.e. a live estimate, which may be a quality that means it could outperform a
moving average. Future research could find the cases in which the Kalman filter proposed here
can outperform simple cumulative or moving averages, and as the filter is a well established
analysis technique plenty of tools exist that could be used to further analyse its results.
As Kalman Filters can be used for tracking of variables, one possible use of it in this case
could be in real time estimation of FC, if MRI technology improved such that the time to capture
BOLD images and process them was faster. For the same reason, the Kalman filter could be
applied to fMRI measured when a participant is performing a task, rather than resting-state
data. This is because a task happens in time, meaning the filter could better track the changing
FC as a task progresses.
A key feature of the Kalman filter is the underlying model, which we have neglected. An
underlying model with the Kalman filter could be used on task based studies, where the model
follows the task. For resting-state data, the underlying model is not so clear; but one based on
physiology could greatly improve its performance. Furthermore, with an underlying model, and
more thorough development of the filter, new predictive methods could be established as this is a












The work in this thesis shows the breadth of areas applicable to network analysis. The twospecific examples we explored were to a gene regulatory network (GRN) and to large scalefunctional brain networks. We showed that by abstracting complex biological systems
into networks we can study simplified elements of them and produce useful insights into their
workings.
Our aim for Chapter 2 was to modify a previously proposed GRN, describing interactions
regulating pluripotency of mouse embryonic stem cells (mESCs), to include genes shown exper-
imentally to be differentially expressed between two different culture media, Serum+LIF and
2i+LIF. Also, as all previous computational models of pluripotency GRNs only considered one of
the inhibitors present in 2i+LIF (i.e. PD), we also aimed at including as a GRN input the other
inhibitor Chiron. A new GRN was derived using published sequencing data, and a stochastic
differential equation model derived to describe the dynamics of genes involved in response to the
two drugs. Previous models were fitted to data generated with a tagged cell line recently shown to
cause an incorrect measurement of the of the key pluripotency gene Nanog, due to high stability
of the fluorescent tag. Instead, we fitted our model on data generated with a new and more
reliable mESC line. We achieved our aims and demonstrated, combining numerical simulations
of the model and bifurcation analysis, that both inhibitors can affect the GRN dynamics and,
ultimately, mESC pluripotency. We also showed that, although not essential to describe Nanog
dynamics, each of the newly added genes and interactions in the GRN can significantly alter the
system dynamics. Limitations of our model are that some of the parameters could not be directly
fitted to data, thus some of the chosen values could be considered arbitrary. The results still bring
useful insights into the broad qualitative, culture media dependent behaviour of pluripotency
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genes in mESCs.
Future work could include performing further network analysis to predict different culture
media protocols to achieve pluripotency maintenance, for example by activating/repressing other
genes in the GRN, and extending the network to include genes and chemicals important for cell
differentiation.
Chapter 3 was a systematic review, carried out to scope the existing literature on the kind
of analysis used to find evidence of neuroplasticity in the brains of participants with multiple
sclerosis (MS). We found that pure resting-state functional magnetic resonance imaging (fMRI)
studies in MS were low in number, though high in quality. We identified six different methods
used to report evidence of neuroplasticity in MS from resting-state fMRI, each having different
advantages and disadvantages. All the studies in the review of Chapter 3 reported some evidence
of neuroplasticity. However, the results were inconsistent between studies, possibly due to the
heterogeneity of MS.
In Chapter 4 we recruited MS and healthy control (HC) participants to have a resting-state
fMRI scan, with the aim of finding evidence of neuroplasticity in MS. We used network analysis
techniques, comparing network properties between MS and HC. Only the average connectivity
within the basal ganglia was found to be significantly different between MS and HC, being
greater in HC. However, after looking at individual pairwise connections within the basal ganglia
and performing a multiple comparisons correction, this significance disappeared. We found no
evidence of neuroplasticity in our cohort of MS, maybe signifying that the MS participants have
already undergone successful neural reorganization. It may be the case that the compensatory
changes in the MS brains are too subtle to be picked up with fMRI, and it may also be that as MS
is a highly heterogeneous disease [44], differences across individuals average out when one looks
at the larger cohort.
Limitations to the work of this chapter are the length of the resting-state scans measured.
Scanning times of 9-13 minutes or longer have been shown to greatly improve the reliability
of fMRI results [11], which is greater than our study which scanned for 4.53 minutes. Another
limitation is in the fMRI technology itself. It can only indirectly measure neuronal activity via the
flow of oxygenated blood, called the blood oxygen level dependent (BOLD) signal. When a region
is more active and requires more oxygenated blood, the BOLD signal does not instantly react.
This delay is the BOLD response, and has a width of approximately 3 seconds, although clever
techniques can make inferences in the 100ms time scale [53]. However, this is still an order of
magnitude greater than the underlying process of neuronal activity, which takes place on a time
scale of approximately 10ms [84]. Furthermore, each voxel that fMRI measures the BOLD signal
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of can comprise thousands of individual neurons. Therefore, although fMRI’s spatial resolution
is greater than other brain imaging methods, it is still not high enough to resolve individual
neuronal activity.
Future work would be to apply the analysis pipeline developed here to other existing data
which already shows evidence of neuroplasticity. This would verify the analysis pipeline or high-
light possible issues with it. Using a different analysis technique, as highlighted in the systematic
review of Chapter 3, could elucidate neuroplasticity in the MS brains. For example, using ICA
or a voxel based analysis. However, more compelling differences would ideally show up over a
variety of methods, i.e. invariant across different analysis techniques. Another analysis technique
we could use is dynamic causal modelling (DCM) [49]. This method infers directed adjacency
matrices, i.e. what region causally influences another region, and is suited to a small number of
regions. This would be ideal for the basal ganglia, being comprised of only six regions, and could
inform on any causal differences in the basal ganglia between the brains of MS and HC.
The work carried out in Chapter 5 was in investigating the application of a Kalman filter
to dynamic functional connectivity (FC). We demonstrate that our filter can track the broad
changes of FC over time, acting qualitatively as a smoother. The filter was only applied to one
case example, generalizing to others could result in unpredictable behaviours. Some details of
the filter still need exploring, such as how the starting parameters (mean and variance) effect it.
Additionally, the Kalman filter demonstrated here effectively neglected any underlying model.
With the addition of this the filter could be used to track and estimate live FC between regions
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